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Use of Contraception in the 
United States: 1982-2008
by William D. Mosher, Ph.D., and Jo Jones, Ph.D., Division o f Vital 
Statistics
Objective
This report presents national 
estimates of contraceptive use and 
method choice based on the 1982,
1995, 2002, and 2006-2008 National 
Surveys of Family Growth (NSFG).
Methods
Data for 2006-2008 were collected 
through in-person interviews with 
13,495 men and women 15-44 years of 
age in the household population of the 
United States. This report is based on 
the sample of 7,356 women interviewed 
in 2006-2008. The response rate for 
women in the 2006-2008 survey was 
about 76%.
Results
More than 99% of women 15-44 
years of age who have ever had sexual 
intercourse with a male (referred to as 
‘‘sexually experienced women'') have 
used at least one contraceptive 
method. The percentage of women who 
have ever used emergency 
contraception, the contraceptive patch, 
and the contraceptive ring increased 
between 2002 and 2006-2008.
Looking at contraceptive use in the 
month of interview, or current use, the 
leading method of contraception in the 
United States during 2006-2008 was 
the oral contraceptive pill, used by 10.7 
million women; the second leading 
method was female sterilization, used 
by 10.3 million women.
While contraceptive use is virtually 
universal in the United States, women 
with different characteristics make 
different choices of methods—for 
example, college educated women are 
much more likely to use the pill and 
less likely to use female sterilization 
than less educated women. Age, parity, 
marital status, and income are also 
closely related to the choice of method. 
These method choices are related to 
the risk of unintended pregnancy in 
these groups.
Keywords: Contraceptive use • birth 
control • pill • National Survey of 
Family Growth
Introduction
For decades, the principal task of 
the Centers for Disease Control and 
Prevention (CDC), National Center for 
Health Statistics (NCHS), Division of 
Vital Statistics (DVS), has been to 
collect and publish the birth and death 
statistics for the United States, as 
required by Section 306 of the Public 
Health Service Act. Producing and 
disseminating these data helps to 
document population change in the 
United States, and provides national and 
state data on infant and maternal 
mortality, prenatal care, birthweight, and 
other important health outcomes.
In 1955 and 1960, nationally 
representative surveys of married 
women were conducted by private 
organizations, in part to understand 
factors behind the baby boom (1). These 
studies yielded important insights, and 
were followed by two more surveys of 
married women in 1965 and 1970, done 
by university researchers with federal 
funding (1,2). By this time, NCHS and 
others recognized the need for NCHS to 
conduct a larger national survey on a 
regular basis to collect data on factors 
related to trends and group differences 
in birth and pregnancy 
rates (1-4).
In response to this need, the 
National Survey of Family Growth 
(NSFG) was conducted by NCHS in 
1973, 1976, 1982, 1988, 1995, 2002, 
and most recently, in 2006-2008. The 
survey collects data on factors related to 
birth and pregnancy rates— as well as 
factors affecting the occurrence of 
intercourse (including marriage, 
cohabitation, and sexual activity); and 
factors affecting the likelihood that
intercourse results in pregnancy and 
birth (including contraception, infertility, 
and the occurrence of miscarriage and 
stillbirth). In addition, a wide variety of 
social, demographic, and economic 
characteristics are collected (1,5,6).
Data from the National Vital 
Statistics System published by NCHS 
show that about 4 million births occur 
in the United States each year (7). About 
40% of the births in the United States in 
recent years are to unmarried women. 
Hispanic and black women have higher 
birth rates and higher percentages of 
births to unmarried mothers than 
non-Hispanic white women (7,8). In 
addition to the 4 million births, about 1 
million miscarriages and stillbirths occur 
in the United States each year, and 
about 1.2 million abortions are 
performed (5,6).
Hispanic and black women have 
higher birth and pregnancy rates, 
especially under age 25, than 
non-Hispanic white women (5,6). For 
example, in 2005 the pregnancy rate for 
women aged 15-44 was 84 pregnancies 
per 1,000 non-Hispanic white women, 
146 for Hispanic women (74% higher 
than the rate for white women), and 139 
for black women (65% higher than the 
rate for white women) (6). The data in 
this report may yield insights into some 
of the factors explaining these 
differences.
The overall pregnancy rate for 
women 15-44 years of age in recent 
years is about 100 pregnancies per 1,000 
women 15-44 per year (9). In other 
words, about 10% of women of 
reproductive age get pregnant in any 
one year. While about one-half of 
pregnancies are intended, the other half 
are unintended, which means that the 
unintended pregnancy rate is about 50
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unintended pregnancies per 1,000 
women per year. Recent analysis shows 
that the unintended pregnancy rate 
varied from 35 per 1,000 white women 
to 98 per 1,000 black women and 78 per 
1,000 Hispanic women per year (9). 
Variations in the unintended pregnancy 
rate by education were equally wide, 
ranging from 26 per 1,000 for college 
graduates to 76 per 1,000 for women 
who did not complete high school (9). 
Patterns of contraceptive use are closely 
related to these variations in unintended 
pregnancy rates, and patterns of 
contraceptive use may be understood as 
both a reaction to these rates of 
unintended pregnancy, and as a factor 
that helps to explain these differences.
The economic and public health 
significance of contraception has long 
been recognized. CDC published a list 
of ‘‘10 great public health achievements 
in the 20th century’’ in 1999, and 
included family planning as one of those 
achievements, noting that:
. . . smaller families and longer birth 
intervals have contributed to the 
better health of infants, children, 
and women, and have improved the 
social and economic role of 
women (10).
In addition to pregnancy prevention, 
the transmission of sexually transmitted 
infections, including HIV, is reduced by 
the use of the male condom. People who 
are unmarried and those with more than 
one partner may more frequently use 
condoms to protect themselves from 
these infections (11, Table 61). Public 
health program planners may use data 
about trends in condom use to tailor 
their programs to those at higher risk of 
these infections.
Researchers have also shown that 
effective contraceptive use reduces 
medical costs associated with 
unintended pregnancy and birth, and 
prevents the health, social, and 
economic costs of adverse outcomes for 
mothers and infants of unintended 
births, including teenagers and 
unmarried mothers (12-14). The most 
effective methods of contraception 
require visits to a doctor, so use of 
contraception is also connected with use 
of health care (15,16). Use of medical
care for birth control and related 
services will be the subject of a future 
report.
Because of the importance of 
contraceptive use in understanding 
birth rates, population change, and 
reproductive and infant health in the 
United States, NCHS has published 
data over several decades documenting 
trends in contraceptive use and its 
variations among subgroups of the 
population (15-18).
To update previous NCHS reports 
on contraceptive use patterns and to 
address the concerns discussed 
previously, this report shows the first 
results from the 2006-2008 NSFG on 
several aspects of contraceptive use:
•  The method (if any) that was used 
at first premarital sexual intercourse.
•  The methods women have ever used 
at some time in their lives.
•  Whether a method of contraception 
was being used at the date of 
interview (current use).
•  Whether those using contraception 
were using one method or more than 
one method.
•  Reasons why women stopped using 
particular contraceptive methods.
•  Reasons for nonuse of contraception 
by women who did not use 
contraception before a recent 
unintended pregnancy.
This report shows trends since 1982 
in several of these measures of 
contraceptive use, as well as differences 
among groups by age, race, education, 
and other characteristics.
Source of the Data
This report is based on the NSFG. 
The NSFG is designed to collect data 
from a national sample on factors 
affecting the formation, growth, and 
dissolution of families—including 
marriage, divorce, and cohabitation; 
contraception, sterilization, and 
infertility; pregnancy outcomes; and 
births (1,5,6). The survey supplements 
and complements the data from the 
NCHS birth registration system by 
providing data that help to understand 
trends and group differences in birth and
pregnancy rates. The NSFG is jointly 
planned and funded by NCHS and 
several other programs of the U.S. 
Department of Health and Human 
Services (see ‘‘Acknowledgments’’).
This report is based on 7,356 
interviews with women 15-44 years of 
age, conducted from about July 1, 2006, 
through December 2008, and from 
comparable samples of women 
interviewed in 1982, 1995, and 2002.
(In 1982, 7,969 women were 
interviewed; in 1995, 10,847 women 
were interviewed; and in 2002, 7,643 
women were interviewed, along with 
4,928 men.) The time trend in this 
report covers the period beginning in 
1982, when highly comparable NSFG 
data on contraceptive use were available 
for all women regardless of marital 
status. This report only includes 
contraceptive use reported by women 
during heterosexual intercourse— 
intercourse that carries a risk of 
pregnancy. Contraceptive use (to prevent 
sexually transmitted infections) during 
other forms of sexual activity is outside 
the scope of the present report. Data on 
contraceptive use as reported by men 
were first collected in 2002 and reported 
in 2006 (19).
Interviewing and data processing for 
the 2006-2008 NSFG were conducted 
by the University of Michigan’s Institute 
for Social Research, under a contract 
with NCHS. In-person interviews were 
conducted by trained professional 
female interviewers in the homes of a 
national sample of households. 
Interviewers entered respondents’ 
answers directly into laptop computers. 
Interviews for women averaged about 
80 minutes in length.
The interview was voluntary; 
participants were provided information 
about the survey before being asked for 
signed informed consent. The survey 
was reviewed and approved by the 
NCHS and University of Michigan 
Institutional Review Boards. The overall 
response rate was 75%; the response 
rate for women was 76%. To protect the 
respondent’s privacy, only one person 
was interviewed in each selected 
household. The interview administered 
to women collected information on her 
births and pregnancies, marriages and
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cohabitations, sterilization operations, 
contraceptive use, infertility, use of 
medical care related to birth control, 
infertility, prenatal care, and social and 
demographic characteristics.
The continuous NSFG is based on a 
new design and fieldwork plan in which 
interviewing is intended to be 
continuous. The sample is a nationally 
representative multistage area 
probability sample drawn from 85 areas 
across the country. The sample is 
designed to produce national, not state, 
estimates. Although the sample design is 
new, the interviewing procedures are 
very similar to those used in previous, 
periodic surveys. Further details about 
how the survey was conducted were 
published in a report in September 
2009 (1). Additional information on the 
methods and procedures of the survey is 
contained in another report (20).
Strengths and 
Limitations of the 
Data
The data in this report have several 
strengths:
•  First, the data are drawn from 
interviews with large national 
samples that were interviewed in 
comparable ways in 1982, 1995, 
2002, and 2006-2008. The NSFG 
also has variables that allow us to 
describe trends by such charac­
teristics as the woman’s age, race, 
education, marital and cohabitation 
status, and her household’s income.
•  Second, the data from each survey 
were processed and coded in ways 
to make them as comparable as 
possible so that trends could be 
measured reliably.
•  Third, the interviews in each cycle 
of the NSFG were conducted in 
person by female interviewers who 
received thorough training on the 
survey.
•  Fourth, the response rates for 
women in the survey were about 
80% in 1982, 1995, and 2002, and 
76% in 2006-2008.
•  Fifth, the survey collected a rich 
array of data on contraceptive use, 
including use of contraception at 
first intercourse after menarche, 
current use of contraception, current 
use of dual or back-up methods, and 
use of specific contraceptives at any 
time in the woman’s life ( ‘‘ever- 
use’’). All of those measures are 
used here to give a more complete 
picture of contraceptive use in the 
United States.
The present report has the following 
limitations:
•  First, the report is intended to 
present some basic statistical facts 
on trends in contraceptive use and 
method choice in the United States 
in the last two and a half decades as 
well as to note differences among 
some important demographic groups. 
The report is not intended to be an 
exhaustive treatment of this very 
complex subject. It presents 
descriptive statistics, and it does not 
attempt to demonstrate cause-and- 
effect relationships.
•  Second, this report presents an 
overview of contraception across 
the ages in which 99.8% of births 
occur (under 45 years of age) (7). 
This report includes summary data 
on contraceptive use for teens, but 
a separate report will present a 
more detailed look at contraceptive 
use and sexual activity among 
teens.
•  Third, this report does not present 
data on contraceptive use for 
individual states because the NSFG 
is designed to provide national, not 
state, data. The NSFG sample would 
have to be much larger than it is to 
provide reliable estimates for 
individual states.
As in any survey, a certain degree 
of nonsampling error may have occurred 
in the NSFG—including possible errors 
of memory, possible misunderstanding 
of what is being asked, and possible 
reluctance to report the information 
being asked for. As noted previously, 
however, extensive efforts to minimize 
such error were made in the design and 
conduct of the survey. In addition,
extensive consistency checking, both 
during the interview and after the data 
were received from the interviewer, was 
implemented to detect such errors, and 
correct them when possible (1,20).
Measurement of 
Contraceptive Use
The scope of this report is limited 
to contraceptive use (as reported by 
women) during heterosexual vaginal 
intercourse. Measuring contraceptive use 
during heterosexual intercourse is one of 
the central goals of the NSFG because it 
is a very important factor affecting birth 
and pregnancy rates and family 
formation. The NSFG questionnaire for 
women begins with some questions on 
demographic background characteristics, 
and then asks detailed questions on any 
pregnancies, births, marriages, or 
cohabitations the woman has had. The 
questions on contraception are next, and 
include:
•  W hether she has ever used each of 
22 methods of contraception at any 
time in her life (Tables 1 and 2 ).
•  Whether she or her partner used any 
of these methods the first time she 
had intercourse after menarche with 
a male (Table 3).
•  What method or methods she is 
using currently (Tables 4 -14).
•  Whether she has stopped using a 
method because of dissatisfaction 
with the method, and what her 
reasons were for that dissatisfaction 
(Table 15).
•  For women who did not use 
contraception before a recent 
unintended pregnancy, the reasons 
they did not use a method 
(Table E ).
The specific contraceptive methods 
discussed here are defined and described 
in many other sources, including some 
for health care professionals (21,22) and 
others for patients (23,24).
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Table A. Estimates of 1-year typical-use failure rates for selected contraceptive methods: 
United States, most recent available data
Typical use, 95%
failure rate confidence
Contraceptive method (percent) interval Rank
Female sterilization.................................................. ...........  Less than 1 NA Highest (most effective)
Male sterilization....................................................... ...........  Less than 1 NA
All methods other than ste riliza tion ...................... ...........  12.4 11.2-13.7
Injectable.................................................................. ...........  6.7 4.3-10.5
P i l l ............................................................................. ...........  8.7 7.2-10.5
Male condom............................................................. ...........  17.4 14.8-20.5
W ithdraw al................................................................ ...........  18.4 13.7-24.2
Periodic abstinence.................................................. ...........  25.3 16.1-37.5
S perm ic ides............................................................. ...........  29.0 NA Lowest (least effective)
NA = S tandard error is not available.
NOTE: Typical-use fa ilure  rate is the  percentage having an unintended pregnancy in 12 months of using a contraceptive method. 
Further details on the  rankings and defin ions are given in the Definitions of Terms under ‘‘E ffectiveness of contraceptive  m ethods.''
SOURCE: Reference 21, p. 15, and Reference 22, p. 226.
Classifying Women by 
Method Use When 
They Are Using Two 
or More Methods
The principal purpose of the 
classification scheme used in 
Tables 4-11 is to measure the extent to 
which women are protected from 
unintended pregnancy by the 
contraceptive methods they are using. 
Therefore, in Tables 4-11 , the 8% of 
women who were currently using more 
than one method are classified by the 
most effective method they reported 
using, because the most effective 
method has the most influence on their 
risk of unintended pregnancy. This 
section defines effectiveness and how it 
is measured in the NSFG. To take the 
most common example, if a woman 
reports that she and her partner are 
currently using the pill and the condom, 
in Tables 4-11 , she is classified as a 
pill user, because the pill is more 
effective— it has a lower failure 
rate—than the condom. In Tables 12-14, 
both methods are counted.
The ranking of the effectiveness of 
methods uses data on failure rates for 
each method when used by a national 
sample of users. A failure rate is simply 
the percentage that has an unintended 
pregnancy in the first 12 months of 
using the method. Much of this 
knowledge is based on analysis of 
data from previous cycles of the 
NSFG (21,22). This measure is 
sometimes called a failure rate during 
‘‘typical use,’’ or ‘‘use-effectiveness’’; it 
is the best estimate of the likely failure 
rate for a national cross-section of users. 
‘‘Perfect use,’’ which is often measured 
in clinical trials, is the failure rate 
obtained when a method is used by a 
selected sample of participants who are 
instructed to use the method consistently 
and correctly; clinical-trial failure rates 
are usually lower than failure rates in 
representative national samples, because 
clinical trial participants usually use the 
methods more consistently than national 
samples do (21,22). Two recent 
sources (21,22) were used to obtain the 
typical-use failure rates shown in
Table A , as estimated from previous 
cycles of the NSFG.
In Tables 4-11, if a woman reported 
that she and her partner had used 
injectable contraception and the condom 
in the last month, she was classified as 
using the injectable, because the 
injectable has a lower failure rate (7%) 
than the condom (17%). In Tables 12­
14, however, both the injectable use and 
the condom use would be recorded. In 
both 2002 and 2006-2008, the questions 
on contraceptive use asked women 
directly about methods used for both 
birth control and prevention of sexually 
transmitted infections, and use of up to 
four methods was recorded.
Statistical Analysis
Statistics for this report were 
produced using SAS software, Version
9.2 (http://www.sas.com). Like all 
survey data, the data in this report are 
affected by sampling errors. This 
report shows measures of sampling 
error (standard errors) for most of the 
2006-2008 statistics presented here. 
The sampling errors were produced 
with SUDAAN software, which is 
designed to compute accurate 
sampling error estimates for complex 
sample designs like the NSFG 
(http://www.rti.org/sudaan). Standard 
errors for the data shown in 
Tables 10-13 are shown in Appendix 
Tables I-IV .
In simple terms, the standard error 
is a measure of the variation of a
statistic (such as a percentage) that 
occurs because the estimate is based 
upon a sample— in this case, because it 
is based on a sample of 7,356 women 
instead of a complete count of the more 
than 61 million women aged 15-44 in 
the United States.
The 95% confidence interval is a 
commonly used measure of the 
sampling error of a statistic. It means 
that in 95% of samples of the size and 
type used here, the estimated percentage 
would fall in that range. In popular 
accounts of surveys and polls, it is often 
called the ‘‘margin of error’’ of the 
survey. The 95% confidence interval of 
the percentages shown in this report can 
be estimated by multiplying the standard 
error by 2 and adding and subtracting it 
from the percentage. For example, if a 
statistic is 20.0% and the standard error 
is 1.5%, then the 95% confidence 
interval is 20, plus or minus 3 (1.5 
times 2), or a range of 17-23%. In this 
example, 95% of samples of that type 
and size would produce estimates 
between 17% and 23%. The 95% 
confidence interval is four times as large 
as the standard error (in this example, 
23-17 = 6, which is four times as large 
as 1.5). When the standard error is 
smaller, the estimate is said to be more 
‘‘reliable’’ or more stable.
All estimates in this report were 
weighted to reflect the female household 
population of the United States.
(Women 15-44 years of age living on 
military bases or in institutions were 
not included in the survey or in this 
report.)
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Percentages were compared using 
two-tailed i-tests at the 5% level. No 
adjustments were made for multiple 
comparisons. Terms such as ‘‘greater 
than’’ and ‘‘less than’’ indicate that a 
statistically significant difference was 
found. Terms such as ‘‘similar’’ or ‘‘no 
difference’’ indicate that the statistics 
being compared were not significantly 
different. If the difference is significant 
at the 10% level but not the 5% level, 
the phrase ‘‘the data suggest’’ is used. 
Lack of comment regarding the 
difference between any two statistics 
does not mean that the difference was 
tested and found not to be significant.
Looking at tables such as Tables 1, 
4 , and 9, which contain trend data from 
several surveys, readers may notice that 
the standard errors for comparable 
statistics are somewhat larger in 
2006-2008 than they were in the 1995 
and 2002 NSFG’s. This issue is 
discussed further in the ‘‘Technical 
Notes,’’ but it does not pose a problem 
in this report or in most analyses of the 
2006-2008 NSFG.
Data by race— The classification of 
race and Hispanic origin in this report 
follows the most recent OMB guidelines 
for the reporting of race in the federal 
statistical system. These guidelines call 
for classifying persons who report one 
race separately from those who report 
two or more. The 7,356 women in the 
2006-2008 NSFG included 1,511 
Hispanic women, 3,780 white women, 
1,381 black women, and 684 women 
reporting another race or more than one 
race. The largest subgroup of this 
‘‘other’’ group was 269 Asian women. 
The ‘‘other’’ group or Asians separately, 
are shown in the tables of this report 
where sample size is large enough to 
compute summary statistics with 
adequate reliability.
To enhance readability, the text of 
this report uses shortened versions of 
the labels for race and origin groups.
For example, the category ‘‘Hispanic or 
Latino’’ is usually referred to as 
‘‘Hispanic,’’ while ‘‘non-Hispanic black 
or African American, single race’’ is 
referred to as ‘‘black’’ in the text; and 
the category ‘‘non-Hispanic white, 
single race’’ is referred to as ‘‘white.’’ 
Women who are ‘‘non-Hispanic other,
single race’’ or ‘‘non-Hispanic, multiple 
race’’ are included in the totals.
See the ‘‘Definitions of Terms’’ for 




Trends in contraceptive use shown 
in Table 1 are for women 15-44 years 
of age who had had intercourse at least 
once (referred to in the text as ‘‘sexually 
experienced’’). The percentages shown 
are the proportions of sexually 
experienced women who reported that 
they (or their male partners) have ever 
used each method of contraception at 
least once, at some time in their lives.
Note that virtually all sexually 
experienced women have used some 
method of contraception: 98% in 1995 
and 2002, and 99% in 2006-2008 
(Figure 1). In 2006-2008, about 93% 
had ever had a partner use the male 
condom; 82% of women had used the 
oral contraceptive pill; and 59% had had 
a partner who used withdrawal. About 1 
in 5 women had used the 3-month
injectable or shot, Depo-Provera™ (22%) 
(Table 1).
The percentage of women who had 
ever used emergency contraception at 
least once increased from 4% in 2002 to 
10% in 2006-2008. Similarly, 1% had 
used the contraceptive patch in 2002, 
compared with 10% in 2006-2008. The 
contraceptive ring was first introduced 
in the United States in 2002; by 
2006-2008, 6% had ever used it. A 
number of newer methods had ever been 
used by small proportions of women in 
2006-2008, including implants (about 
1%) and Lunelle™, a 1-month 
injectable (2%) (Table 1).
Data on the percentage of women in 
2006-2008 who have ever used 
particular methods by race and Hispanic 
origin are presented in Table 2 . Only 
56% of Asian women and 68% of 
Hispanic or Latina women have ever 
used the pill compared with 89% of 
white and 78% of black women. 
Fourteen percent (14%) of Hispanic 
women had ever used an IUD compared 
with 6% of white and black women and 
3% of Asian women. In contrast, 
however, 30% of black women, 26% of 
Hispanic women, and 19% of white 
women, have ever used the 3-month 
injectable contraceptive, Depo-Provera™ 
(Figure 2).
Figure 1. Percentage of sexually experienced women aged 15-44 years who have ever used 
the specified contraceptive method: United States, 1982, 2002, and 2006-2008










Figure 2. Percentage of sexually experienced women aged 15-44 years who have ever used 
the specified contraceptive method, by race and Hispanic origin: United States, 2006-2008
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SOURCE: Table 3.
Figure 3. Percentage of women aged 15-44 years who used a method of contraception at 
their first premarital intercourse: United States, 2006-2008
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Contraceptive Use at First 
Premarital Intercourse
Table 3 shows the percentage of 
women who used (or whose partner 
used) a method of contraception at her 
first premarital intercourse after 
menarche. Use at first premarital 
intercourse is important because 94% of 
women 15-44 have had premarital 
intercourse (25), and first intercourse 
after menarche marks the beginning of 
exposure to the risk of nonmarital 
pregnancy and birth. Teenagers who do 
not use a method of birth control at first 
intercourse after menarche are about 
twice as likely to become teen mothers 
as teens who do use a method at first 
intercourse after menarche (26).
The first panel of Table 3 shows the 
proportion using contraception at first 
premarital intercourse by the year that 
the first intercourse occurred as a way 
to look at trends over the last two 
decades. Among women whose first 
premarital intercourse occurred before 
1985, 56% used a method; that 
proportion rose to 76% in 2000-2004 
and 84% in 2005-2008 (Figure 3).
Much of this increase was due to an 
increase in condom use, from 34% 
before 1985 to 72% in 2005-2008.
The second panel of Table 3 shows 
the proportion using a method by a 
woman’s age at her first premarital 
intercourse. The largest difference in this 
panel is that 11% of women who had 
their first premarital intercourse before 
age 16 used the pill at first intercourse 
after menarche, compared with 25% of 
women whose first intercourse was at 
age 20 or older.
About 84% of women whose 
mother had a college education used a 
method at first premarital intercourse. 
Among women whose mothers did not 
finish high school, only 53% used a 
method at first premarital intercourse. 
Most of this difference is in condom use 
(68% compared with 37%) (Table 3).
Finally, 76% of non-Hispanic 
white women used a method at their 
first premarital intercourse compared 
with 65% of black women and 52% of 
Hispanic women. The lower 
percentage of Hispanic women using a 
method at their first intercourse after
menarche has been observed for 
decades (16,26,27).
The bottom panels of Table 3 
present trends in use at first premarital 
intercourse for Hispanic, white, and 
black women separately, by showing use 
when first premarital intercourse 
occurred: before the year 2000 for each 
group, and then use when first 
premarital intercourse occurred in 2000
or later. For women whose first 
premarital intercourse occurred before 
the year 2000, 73% of white women and 
45% of Hispanic women used a method 
at first premarital intercourse, a 
difference of 28 percentage points. For 
women whose first premarital sex 
occurred in 2000 or later, 85% of white 
women and 64% of Hispanic women 
used a method, a difference of
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NOTE: See Table 4 fo r m ore detail.
Figure 4. Percent distribution of women aged 15-44 years, by current contraceptive status: 
United States, 2006-2008
21 percentage points. These figures 
suggest that the difference, although still 
large, appears to be narrowing somewhat 
in recent years.
Current Contraceptive Use
Table 4 shows a third measure of 
contraceptive use: ‘‘current’’ use, 
meaning use during the month of 
interview, in 2006-2008. This measure, 
published many times before from 
previous cycles of the NSFG 
(15-18,28), shows the percentage of 
women aged 15-44 in each of several 
categories:
•  First, women are classified by 
whether they were using a method, 
or not using a method in the month 
of interview. In 2006-2008, about 
62% of these 62 million women 
were currently using a method of 
contraception, including male 
methods such as vasectomy, 
condom, and withdrawal (Table 4 
and Figure 4).
•  Those who were currently using a 
method (‘‘contraceptors’’) are shown 
by the method they are using. In 
Tables 4-11 , those using more than 
one method are classified by the 
most effective method they are 
using. (See ‘‘Classifying women by 
method use when they are using two 
or more methods’’.)
•  Those who are not using a method 
in the month they were interviewed 
in 2006-2008 (38% as shown in 
Table 4 and Figure 4) were classified 
by the main reason they were not 
using contraception, including:
■ 5.4% were currently pregnant or 
postpartum.
■ 4.1% were trying to become 
pregnant.
■ 19.2% had never had intercourse, 
or had not had intercourse in the 
last 3 months.
■ 0.4% were sterile from surgery 
(most commonly, hysterectomy).
■ 1.7% were sterile for non- 
surgical reasons.
In the following statistics, all of 
these groups of nonusers of contra­
ception are classified as not ‘‘at risk of 
unintended pregnancy.’’
The remaining 7.3% (about 4.5 
million women) have had intercourse in 
the last 3 months but were not currently 
using contraception. These women may 
be the most at risk of unintended 
pregnancy. This proportion was about 
the same in 2002 and 2006-2008.
Among the 62% of women who 
were using a method of contraception in 
2006-2008, the leading methods 
currently used were:
•  The oral contraceptive pill, used by 
17.3%, or 10.7 million women.
•  Female sterilization, used by 16.7%, 
or 10.3 million women.
•  Male sterilization (vasectomy), used 
by the partners of 6.1%, or 3.7 
million women.
Estimates of use of the male condom 
are discussed in the following text.
Current use by age, race and 
Hispanic origin, and marital 
status
Tables 5-7 show the percentage of 
all 62 million women by their ‘‘current 
contraceptive status’’—using the same 
categories as in Table 4 , for categories 
of age, race and Hispanic origin, and 
marital status.
The percentage using contraception 
varies by age (Table 5). At age 15-19,
only 28% were currently using 
contraception, because many have not 
had intercourse ever, or in the last 3 
months. At age 20-24, the proportion 
using contraception rose to 55% and 
from 25-44, it was between 64% and 
78%.
The leading methods change with 
age (Table 5). Among women under 30, 
a higher percentage of women used the 
pill than any other method. (For 
example, at age 20-24, 26% were using 
the pill, much higher than the percent 
using any other method.) At ages 30-44, 
the leading method was female 
sterilization. These patterns are 
comparable to findings in previous 
cycles of the NSFG.
The data on current contraceptive 
use for Hispanic or Latina women, 
non-Hispanic white, non-Hispanic black 
or African American, and other women 
are shown in Table 6. A sian women are 
shown in the table but not emphasized 
in the text because their smaller sample 
size makes their statistics subject to 
more sampling variation than the other 
groups. The three largest groups— 
Hispanic, white, and black—differ in the 
use of the pill and male and female 
sterilization. The proportion using 
female sterilization was 22% for black 
women, 20% for Hispanic women, and 
15% for white women (Figure 5). Male
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Figure 5. Percentage of women aged 15-44 years using selected contraceptive methods, by 
race and Hispanic origin: United States, 2006-2008
sterilization was used by 8% of the male 
partners of white women, but it was 
used by only 3% of the partners of 
Hispanic women and 1% of the partners 
of black women.
Note that the sum of the proportion 
using male sterilization or female 
sterilization was 23% for each of these 
three groups of women. Thus, the 
proportion of all three groups using 
sterilization was the same, but they 
differed in whether they used male or 
female sterilization.
These groups also differed in use of 
the pill: 21% of white women used the 
pill compared with 11% of Hispanic and 
black women. Asian women differed 
most from other women in their reliance 
on their partners to use condoms: about 
9% of white, black, and Hispanic 
women relied on a male partner to use 
the condom compared with 26% of 
Asian women.
Table 7 shows the data by marital 
and cohabitation status:
•  Legally married.
•  Not married but currently cohabiting 
(living in a sexual relationship) with 
a man.
•  Formerly married (divorced, 
separated, or widowed) and not 
cohabiting.
•  Never-married and not cohabitating.
These groups vary in characteristics 
that affect contraceptive use, such as 
their age and the number of children 
they have had. Based on the 2006-2008 
NSFG, married women aged 15-44 
were 34 years of age on average at the 
date of the interview, and formerly 
married women were 36 years of age. 
Cohabiting women averaged 29 years of 
age and never married women only 23 
years of age. About 80% of never 
married women had never had a child 
compared with 20% of currently married 
women (Table B).
The percentage using contraception 
varies between never married women 
and the other marital status groups 
because 46% of never married women 
have not had intercourse recently (or 
ever), while the other groups have much 
smaller proportions who have not had 
intercourse in the last 3 months 
(Table 7). It is sometimes desirable to 
determine the percentage of all women 
who are using particular contraceptive 
methods, as in Table 7 . F or example,
Table B. Average age and percentage childless
Marital
status
Currently m a rried ..................................................................
C ohab iting .............................................................................
Formerly m a rrie d ..................................................................
Never m a rried ........................................................................
18% of never married women, 23% of 
cohabiting women, and 16% of 
married women, were using the pill 
in 2006-2008.
Percentage Using A Method 
Among Those at Risk of 
Unintended Pregnancy
Table 8 shows the percentage of 
women using any method of 
contraception by various characteristics. 
While it does not show the detailed 
categories for nonuse that were shown 
in Tables 4 -7 , it does show the 
percentage using (and not using) 
contraception by more characteristics of 
the women (for example, education and 
income). About 62% of all women 
15-44 were using contraception in 
2006-2008. The proportion is 
significantly lower for four groups, 
which are shown in Table 8: teenagers 
15-19 years of age, 28%; never married, 
noncohabiting women (some of whom 
are teens), 39%; childless (parity 0) 
women, 44%; and women who intend to 
have (more) children in the future, 47%.
Since different percentages of these 
groups have had intercourse recently (or 
ever), it is often useful, especially when 
comparing contraceptive use patterns 
among groups that may differ by marital 
status or age, to describe the proportion 
of women using contraception as a 
percentage of those at risk of unintended 
pregnancy. One definition of that 
percentage is shown in Table 8 and 
discussed in the following text. An 
alternative definition is described in the 
‘‘Definitions of Terms.’’
As defined in this report 
(Tables 4 -8 ), at risk of unintended 
pregnancy includes all women who are 
not using contraception but who had had 
intercourse in the last 3 months, plus 
those who are having intercourse and 
are using contraception. Those using
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Figure 6. Percentage of women aged 15-44 years at risk of unintended pregnancy who 
were not using contraception, by Hispanic origin and race: United States, 2006-2008
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contraception are ‘‘at risk of unintended 
pregnancy’’ because there is a risk that 
their use of the method could fail and 
result in unintended pregnancy. Women 
who are ‘‘not at risk’’ are excluded from 
the denominator. Women are categorized 
as ‘‘not at risk’’ if
•  They were currently pregnant.
•  Trying to get pregnant.
•  Sterile for health reasons.
•  Had never had intercourse.
•  Had not had intercourse in the last 3
months.
Note that these categories are 
shown in Tables 4 -7  and that all 
contraceptive methods, including male 
and female sterilization, are included as 
‘‘at risk and using a method’’ in this 
classification. For further details on this 
classification, and an alternative 
definition, see ‘‘At risk of unintended 
pregnancy’’ under ‘‘Definitions of 
Terms’’).
Table 8 shows the percentage of all 
women and the percentage of women at 
risk of unintended pregnancy who were 
using (and for women at risk, not using) 
a contraceptive method in the month of 
interview. The percentage of all women 
using a method was 62%; the 
percentage of those at risk using a 
method was 89%. While 28% of all 
teenagers were using contraception at 
the date of interview, 81% of teens at 
risk were using contraception. Looking 
at childless (parity 0) women, 44% of 
all childless women were using 
contraception, but 86% of childless 
women at risk of unintended pregnancy 
were using a method.
Still, that means that 14% of 
childless women who do not want to 
have children right away and 19% of 
teens who do not want children right 
away were not using contraception. 
Further, there are differences among 
subgroups by Hispanic origin and race. 
The percentage of black women at risk 
of unintended pregnancy who were 
using contraception was 84% compared 
with 91% of Hispanic and white women 
and 92% of Asian women.
Stated another way, 16% of black 
women, and about 9% of Hispanic, 
white, and Asian women at risk of 
unintended pregnancy were not using 
contraception in 2006-2008 (Table 8 and
Figure 6). This fact may be related to 
the higher rates of unintended pregnancy 
among black women compared with 
non-Hispanic white women (9).
Contraceptors: Trends in 
Contraceptive Use
Tables 9-13 show similar data as in 
Tables 4 -7 , with a different 
denominator. Tables 4 -7  show the 
percent of all 62 million women 15-44 
in 2006-2008 who were using particular 
contraceptive methods, while 
Tables 9-13 show the distribution by 
method of the 38 million women using 
any method of contraception. They are 
referred to as tables of ‘‘contraceptors.’’ 
These tables answer the question: ‘‘Of 
those who are using contraception, what 
percent are using each method?’’
Of the 38.2 million women using a 
method in 2006-2008, about 27% were 
using female sterilization, a proportion 
that has been stable since 1995. The pill 
accounts for about 28% of contraceptive 
users; this is also similar to the pro­
portions found in 1982, 1995, and 2002.
But there have been some changes 
over the last two and a half decades. In 
1982, 8% of U.S. contraceptors were 
using the diaphragm, but by 2006-2008, 
use of the diaphragm had virtually
disappeared (the NSFG estimate is 
indistinguishable from zero). In 1982,
7% of contraceptors were using IUD’s; 
that figure dropped to 1% in 1995 and 
2% in 2002, but by 2006-2008, 5.5% of 
contraceptors (2.1 million women) were 
currently using IUDs.
Table 10 shows the percentage 
distribution of current contraceptive 
users by several characteristics that give 
some insight into the factors that affect 
contraceptive choice. The data are 
shown for both 2002 and 2006-2008 to 
measure recent trends. (Standard errors 
for Table 10 are shown in Appendix 
Table I .)
•  The proportion of contraceptors 
choosing female sterilization 
increases with age to 50% of 
contraceptors at age 40-44 years. 
This occurred in both 2002 and 
2006-2008 (Table 10 and Figure 7).
•  Use of the pill declines as age 
increases: 54% of contraceptors 
under 20 years were currently using 
the pill compared with 11% at age 
40-44 (Figure 8).
•  Among currently and formerly 
married women, the leading method 
was female sterilization; among 
cohabiting and never married 
women, the leading method was the 
pill.
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Figure 7. Percentage of contraceptors aged 15-44 years using female sterilization, by age: 
United States, 2006-2008
Age at interview
NOTE: See Table 10 fo r m ore detail.
Figure 8. Percentage of contraceptors aged 15-44 years using the pill, by age: 
United States, 2006-2008
•  Among contraceptors with no births, 
55% were using the pill compared 
with just 8% of those with three or 
more births. Among women with 
three or more children, 59% were 
using female sterilization (Figure 9).
•  The proportion of contraceptors 
using the IUD increased from 2% in 
2002 to 8% in 2006-2008 among 
women with one child, and from 3%
to 11% among women with two 
children (see data by ‘‘parity’’ in 
Table 10). Smaller increases in IUD 
use appear to have occurred among 
currently married, cohabiting, and 
never married women (Table 10).
Table 11 shows contraceptive users 
by four additional characteristics of the 
woman: her education, her household’s
income, whether she intends to have any 
more births, and her race and Hispanic 
origin. The data are shown in both 2002 
and in 2006-2008, to measure trends 
within these groups, and to see if the 
differences between groups have 
changed. (Standard errors for Table 11 
are shown in Appendix Table II.)
•  Less-educated women aged 22-44 
years were much more likely to rely 
on female sterilization than those 
with more education. In 2006-2008, 
55% of women who had not 
finished high school were using 
female sterilization compared with 
only 16% of those who had 
graduated from college (Figure 10 
and Table 11). Findings were similar 
in 2002.
•  Use of the pill, in contrast, increased 
as education increased, from 10% in 
the lowest education group to 35% 
of college graduates (Figure 11).
•  Women who intend to have children 
(or more children) in the future are 
using contraception to space or 
delay their next birth. Nearly 
one-half of these women (48%) 
were using the pill in 2006-2008 
and 27% were using the condom.
•  In contrast, women who do not 
intend to have more children rely 
primarily on female sterilization 
(44%). An additional 16% rely on 
male sterilization and 16% on the 
pill.
•  Non-Hispanic white women were 
less likely to rely on female 
sterilization, and more likely to rely 
on male sterilization or the pill 
compared with Hispanic and black 
women. This pattern was also found 
in 1995 and 2002 (15,16).
•  IUD use appears to have increased 
from 2% to 6-7% among the top 
two education groups and in the top 
two income groups (Table 11). For 
example, among contraceptors with 
a bachelor’s degree or higher, the 
proportion using the IUD increased 
from 2% to 6% from 2002 to 
2006-2008. The proportion using 
the IUD increased from 1.5% to 
5.9% among women with household 
incomes of 300% of the poverty 
level or higher (about $60,000 for a 
family of four).
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Figure 9. Percentage of contraceptors aged 15-44 years who were using female 













Figure 10. Percentage of contraceptors aged 22-44 years who were using female 
sterilization, by education: United States, 200S-2008
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Use of More Than One 
Contraceptive Method: 
Dual and Multiple Use
Most women report using at most 
only one contraceptive method in any 
given month, but for the 8% of all 
women who were using two or more 
methods in the month of interview, 
Tables 4-11 present only the most 
effective method they were using. In the 
2006-2008 NSFG (as in the 1995 and 
2002 surveys), up to four methods of 
contraception were collected and coded 
for the month of interview and for each 
month in the preceding 3-4 years. It 
was therefore possible to measure the 
total percentage of women who were 
using a given method of contraception 
in these months, even if they were also 
using another method in that month. 
When multiple contraceptives are used 
in the same month, it may occur for any 
of a number of reasons, such as:
•  Two methods are used at the same 
act of intercourse; for example, the 
oral contraceptive pill and the male 
condom may be used at the same 
act of intercourse—the pill to 
prevent pregnancy and the condom 
to prevent sexually transmitted 
infections.
•  One is used as a substitute for another 
method when the other method is not 
available. For example, withdrawal 
may be used as a substitute when the 
condom is not available.
•  When one method is used with one 
partner and a second method is used 
with another partner.
Thus, Tables 4-11 , discussed 
previously, show one method per 
woman because most contraceptive 
users only use one method at a time, 
and because the principal goal of that 
measure was to determine how well 
women were protected from unplanned 
pregnancy. In recent years, however, 
questions have been included in the 
NSFG that have made it possible to 
measure dual or multiple use. This was 
done in part because it has become 
important to measure how well 
protected women and men are from HIV 
and other sexually transmitted infections 
as well as unplanned pregnancies. And as
shown in the following text, one important 
question that can be answered with these 
data is, ‘‘How many women’s male 
partners are currently using the condom?’’ 
The extent of use of more than one 
current method can be measured directly 
by tabulating the percentage of women 
who used more than one method in the 
month of interview (Table C).
Thus, as a share of all women, the 
proportion using two or more methods 
of contraception in the month of 
interview was 8% overall and ranged 
from about 5-11% in the subgroups in 
Table C . A s a share of contraceptors 
(women using some method of 
contraception), about 14% were using 
more than one method. The proportion




Figure 11. Percentage of contraceptors aged 22-44 years using the pill, by education: 
United States, 200S-2008
Table C. Percentage of women using more than one contraceptive method, by marital 












T o ta l................................................................................... 8.4 13.5
Marital status
Currently m a rried ............................................................. . . 8.0 10.1
Never m arried .................................................................. . . 8.0 20.2
Formerly m a rrie d ............................................................. . . 8.7 13.4
C oha b iting ........................................................................ 11.5 16.0
Hispanic origin and race
Hispanic............................................................................. . . 5.2 8.8
Non-Hispanic white, single r a c e .................................... . . 9.2 14.2
Non-Hispanic black, single r a c e .................................... 8.9 15.6
Age
15-24 y e a rs ..................................................................... . . 8.3 20.1
25-34 y e a rs ..................................................................... . . 10.7 15.9
35-44 y e a rs ..................................................................... 6.5 8.2
1Denom inator includes current contraceptors and noncontraceptors. 
2Denom inator only includes current contraceptors.
of contraceptors using more than one 
method was greatest for never married 
women, black and white women, and 
15-34-year-olds. The male condom is 
the most commonly used second method 
and is often used to protect the couple 
from sexually transmitted infections.
Table 12 shows data on use of each 
method by marital status; Table 13 by
Hispanic origin and race; and Table 14 
by age. (Standard errors for Tables 12, 
13, and 14 are shown in Appendix 
Tables III, IV, and V, respectively.) 
Looking at the percentages in Table 12, 
for most methods of contraception, the 
figures are virtually identical regardless 
of whether the percentages are in the 
‘‘most effective method’’ or the ‘‘any use’’
column. However, there are at least two 
noticeable differences, as shown in 
Table D .
The current contraceptive status 
code used in Tables 4 -8 , which shows 
one method per woman, gives a 
virtually complete count of current 
method use for nearly all methods, 
except two male methods: the (male) 
condom, which increased from 6.2 to
8.6 million users, or by 2.4 million, 
when dual or multiple use is accounted 
for, and withdrawal, which increased 
from 2.0 to 3.8 million users, when 
multiple use is accounted for. Thus, the 
number of current condom users in the 
United States in 2006-2008 was about
6.2 million using the condom as their 
most effective (and usually primary) 
method, but the total number of women 
whose partner used a condom was about
8.6 million (Table D ). Figure 12 and the 
following data show that accounting for 
dual or multiple use increases the 
proportions of women whose partners 
were using the male condom or 
withdrawal, particularly for the unmarried.
These findings are useful for future 
studies of contraceptive use, pregnancy 
rates, and contraceptive failure rates. For 
example, if withdrawal is used as a 
back-up method when a more reliable 
method is not available, unintended 
pregnancy may be more likely to result 
than if the primary method (e.g., the 
pill) had been used, but less likely than 
if no method were used. If the male 
condom is used at the same act of 
intercourse as the pill, protection from 
infection is increased. With data such as 
these, future studies can address how 
effective such back-up use (of the 
condom or withdrawal) is.
Among unmarried women, 14.0% 
were relying on their partner to use a 
condom, including 8.6% for whom it 
was their most effective method and 
5.4% who were also using another, more 
effective method of birth control. These 
percentages are equivalent to 5.3 million 
and 3.3 million unmarried condom users, 
respectively (Table 12 and Figure 12).
Table 13 shows similar data by 
Hispanic origin and race. The proportion 
of black women relying on the condom 
as their most effective method was 
8.8%, but including condom use along 
with another method (such as the pill), the
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Table D. Percentage of women whose partners used the condom or withdrawal as most
effective method or any use: United States, 2006-2008
proportion using the condom was 14.8%, 
an increase of 6.0 percentage points.
At age 15-24 years, the percentage 
using the condom increases 5.5 percentage 
points— from 9.9% to 15.4%—when dual 
use of the condom is counted (Table 14). 
Among 25-34-year-olds, the proportion 
using the condom rises from 12.6% to 
17.7% when counting dual or multiple 
use. But at age 35-44 years, this increase 
is only 1.3 percentage points, from 7.6% 
to 8.9% when counting dual or multiple 
use.
Further research on the factors 
leading to dual and multiple use is 
possible with these data, and may lead 
to a better understanding of how women 
and couples try to manage the risks of 
both pregnancy and sexually transmitted 
disease.
Stopping Use of 
Contraceptive Methods
Table 15 shows another important 
aspect of contraceptive use: the reasons 
why women stop using some prominent 
birth control methods. The table shows:
•  The number of women who have 
ever used four prominent 
contraceptive methods.
•  The percentage of those who 
discontinued the method because 
they were dissatisfied with it.
•  For those who discontinued a 
method due to dissatisfaction, the 
proportion who gave the specific 
reason for stopping the method. 
Women were asked: ‘‘Some people 
try a method and then don’t use it 
again, or stop using it, because they 
are not satisfied with the method. 
Did you ever stop using a method 
because you were not satisfied with 
it in some way?” If she answered 
yes, she was asked, ‘‘What method 
or methods did you stop because 
you were not satisfied?”
•  An estimated 45 million women had 
ever used the pill (Table 15). Of 
those, 30% (or 13.6 million) had 
discontinued the pill because they 
were dissatisfied with it.
•  About 12 million women had 
ever used the 3-month injectable 
(Depo-Provera™), and 43% of them 





•  About 5.4 million women had ever 
used the contraceptive patch, and 
one-half (50% or 2.7 million) had 
discontinued it.
The percentages that follow are 
percentages of the 13.6 million who 
stopped using the pill, the 5.3 million 
who stopped using the condom, the 5.2 
million who stopped using the 
Depo-Provera™ injectable, and the 2.7 
million who stopped using the patch. It 
should be noted that women could have 
used and discontinued more than one of 
these methods.
Table 15 shows percentages of those 
who discontinued the method for each 
of the reasons listed. Women could give 
more than one reason.
Pill
About two out of three (64%, or 8.6 
million) of the 13.6 million women who 
stopped using the pill stopped because 
of side effects that they attributed to the
Most effective method Any use
10.0 (6.2 million) 13.9 (8.6 million)
3.2 (2.0 million) 6.2 (3.8 million)
pill; in addition, 13% (1.7 million) said 
they stopped because they were worried 
about side effects. About 11% stopped 
because they did not like changes to 
their menstrual cycle when they used 
the pill; 10% (1.4 million) stopped 
because they got pregnant, and 10% 
stopped because they said the pill was 
too difficult to use (e.g., too difficult to 
remember to take it every day). Looking 
at these results for the pill for Hispanic, 
white, and black women (Table 15), the 
overall patterns are similar: the 
percentages of women who stopped 
because of side effects and the other 
main reasons are similar for Hispanic, 
white, and black women.
Depo-Provera™
For the 3-month injectable, 5.2 
million women discontinued the method 
because they were dissatisfied with it.
As with the pill, most women who 









Figure 12. Percentage of women aged 15-44 years whose most effective method of 
contraception was the condom, and percentage who used the condom with or without 
another method (‘‘any use’’), by marital status: United States, 2006-2008
0
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Table E. Among women who did not use contraception before a recent unintended birth, 
percentage and standard error citing each reason for not using contraception:
United States, 2006-2008
Reason for not using contraception Percent Standard error
Did not expect to have s e x .................................................. 14.1 3.11
Did not think you could get p regna n t................................. 43.9 6.14
Didn’t really mind if you got pregnant................................. 22.8 4.68
Worried about side effects of birth c o n tro l......................... 16.2 3.64
Male partner didn’t want you to use birth con tro l.............. 7.3 2.07
Male partner didn’t want to use birth control...................... 9.6 3.06
NOTE: Percentages add to  more than 100 because wom en were allowed to  give more than one reason fo r nonuse of 
contraception.
(76%, or 4.0 million) and one-fourth 
(26% or 1.3 million) stopped because 
they didn’t like the changes to their 
menstrual cycles. Very few (2%) 
stopped because they got pregnant.
Condom
As might be expected, the patterns 
of reasons for stopping use of the 
condom are different than for the 
hormonal methods: the leading reasons 
for stopping use of the condom were 
that the partner did not like using 
condoms (41%, 2.2 million) and that it 
decreased sexual pleasure (40%, or 2.1 
million). The next-most cited reason was 
that the woman ‘‘worried that the 
method would not work’’ (23%, or 1.2 
million). Only 5.2% stopped using the 
condom because they got pregnant.
None stopped because it was too 
difficult to obtain.
Reasons for Nonuse of 
Contraception Leading to 
Unintended Pregnancy
Women in the NSFG who had had 
an unintended pregnancy in the 3-4 
years before the interview were asked 
whether she or her partner were using 
contraception when she became 
pregnant. If she said that they were not 
using a method, she was shown a card 
with a list of frequently cited reasons 
for nonuse. Those reasons were:
•  ‘‘You did not expect to have sex.’’
•  ‘‘You did not think you could get 
pregnant.’’
•  ‘‘You didn’t really mind if you got 
pregnant.’’
•  ‘‘You were worried about the side 
effects of birth control.’’
•  ‘‘Your male partner did not want 
you to use a birth control method.’’
•  ‘‘Your male partner did not want to 
use a birth control method.’’
Table E shows the results of this 
inquiry into the reasons for nonuse of 
contraception that lead to unintended 
pregnancy. The statistics in this table 
are based on 842 women in the NSFG 
sample, compared with thousands in 
most other tables in this report, so 
small differences should be interpreted
with caution. However, the general 
pattern is clear: the leading reason 
given for nonuse of contraception was 
‘‘You did not think you could get 
pregnant,’’ cited by 44% of these 
women who had unintended 
pregnancies in recent years. About 
14% said that they did not expect to 
have sex, 23% said they ‘‘didn’t really 
m ind’’ if  they got pregnant, and 16% 
said they were ‘‘worried about the side 
effects’’ of birth control methods. The 
proportions of women citing the other 
reasons were smaller.
Given these findings—that many 
women who became pregnant did not 
think they could get pregnant— further 
research on factors related to nonuse 
and inconsistent use of contraception 
could be useful. A recent report on a 
national telephone survey suggested 
some possible explanations of nonuse 
and inconsistent use of contraception 
among unmarried males and females 
18-29 years of age in the United 
States (29).
International Comparisons
The persistence of the patterns of 
contraceptive use in the United States 
in the last two decades raises 
questions about whether these patterns 
are similar to those in other high- 
income countries with birth rates as 
low or lower than in the United States. 
Data on contraceptive use in many 
countries of the world are compiled 
and published by the United Nations 
Population Division (30). Similar 
compilations are published by the 
Population Reference Bureau (31,32). 
In Table F, the data from the United 
Nations (30) are compared with data 
from this report for the United States.
The total fertility rate (or TFR) is 
the average number of births per 
woman, based on current age-specific 
birth rates. In the United States in 2005 
and 2006, the TFR was about 2.1 
children per woman (7,30). Table F 
shows data for the most recent year 
available for a number of developed 
countries that had birth rates (TFRs) as 
low as or lower than the United 
States (30-33), from a recent United 
Nations compilation of data on 
contraceptive use in many countries of 
the world. The data in Table F are based 
on national surveys conducted by 
government agencies. Results are based 
on large samples, and are adjusted to 
national population totals. (Further 
details are given in Table F and in 
‘‘Appendix III.’’) While international 
comparisons always require caution 
because of differences in such procedures 
as sampling methods, data collection 
procedures, and question wording, some 
patterns seem clear from these data:
•  In several of these countries, the 
proportion using the pill was much 
higher than the 16-17% in the 
United States. For example, the 
proportion using the pill was over 
40% in France, Belgium, the 
Netherlands, and Portugal, and over 
30% in Norway.
•  In two of these countries, France 
and Norway, the proportion using 
the IUD was over 20% compared 
with just 5% in the United States in 
2006-2008.
•  In the United States, 11-13% of 
married couples were using male 
sterilization and 22-24% were using 
female sterilization (a total of 
33-35% or about one-third of 
couples). The proportion using 
sterilization was 28% in Australia
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Table F. Percentage of married couples, and percentage of all women, using each method in selected countries with total fertility rates 
lower than in the United States
Selected countries TFR
Any









United States, 2006-2008................ . . 2.1 79 16 5 12 13 24 9
France, 2000...................................... . . 2.0 82 44 22 5 NA NA 11
Netherlands, 2003.............................. . . 1.8 67 41 4 8 8 4 2
Spain, 2006......................................... . 1.3 66 17 6 25 8 6 4
United Kingdom 2007-2008............. 1.8 82 29 6 27 19 9 0
All marital statuses
United States, 2006-2008................ . . 2.1 76 21 4 12 8 21 10
Belgium, 2004 .................................... . 1.7 75 45 10 NA NA NA 20
Norway, 2005....................................... . 2.0 88 31 23 13 0 8 13
Portugal, 2005-2006 .......................... . 1.3 67 45 6 9 0 0 7
Australia, 2001-2002......................... 1.8 71 24 1 15 14 14 13
1 “All other m ethods’’ includes male and fem ale sterilization fo r countries with NA (m eaning ‘‘not availab le ’’) in the  male and fem ale sterilization colum ns. In the  data fo r Belgium, male condom  use is 
included under ‘‘all o ther m ethods.’'
NOTES: Data for all countries listed are from  national surveys in the years indicated. Results are  based on large samples and are adjusted to  national tota ls in each country. Further details are shown 
in the  Appendix. For ‘‘all marital sta tuses,’’ data are lim ited to  wom en who had sex in the  past 3 or 12 months. See A ppend ix III.
SOURCES: For 2 00 6-20 0 8  U.S. contraception data, see Table 7 of this report. For 2002 U.S. contraceptive data, see M osher et al., Table 8. For data on Total Fertility Rates (TFR), see Reference 30. 
For data on contraceptive  use in selected countries, see UN Population Division, ‘‘C ontraceptive  Prevalence, 2009 ,’’ available from: h ttp ://ww w.un.org/esa/population/pub lications/W CU2009/M ain .htm l.
and the United Kingdom, but use of 
male and female sterilization as a 
method of birth control was much 
less common in the other countries. 
•  The proportion relying on the male 
condom was about 25% in Spain 
and 27% in the United Kingdom, 
about double the proportion in the 
United States (12%).
These differences undoubtedly have 
many causes, including cultural and 
legal factors, economic conditions, and 
patterns of health care use and payment; 
the reader is referred to the references 
for further discussion (14,29,34,35). But 
the comparisons do suggest that 
countries with TFRs as low as or lower 
than in the United States often use 
sterilization less than in the United 
States. These countries also often rely 
more on the pill, and sometimes on the 




This is the first report of findings 
from the 2006-2008 National Survey 
of Family Growth (NSFG). The 
findings are based on interviews with 
a national sample of 7,356 women 
aged 15-44. Future reports based on
the interviews with both men and 
women will describe many other 
aspects of fertility and family life in 
the United States.
Contraceptive use in the United 
States is virtually universal among 
women of reproductive age: 99% of all 
women who had ever had intercourse 
had ever used at least one contraceptive 
method in their lifetime (Table 1 and 
Figure 1. In 2006-2008, 93% (49.5 
million) had ever had a partner who 
used the male condom, 82% (43.8 
million) had ever used the oral 
contraceptive pill, and 59% (31.3 
million) had ever had a partner who 
used withdrawal.
But that does not mean that 
contraceptive use in the United States 
is completely consistent or effective. 
One-half of all pregnancies in the 
United States are unintended (9), and 
the average probability of an 
unintended pregnancy in 12 months of 
contraceptive use in the United States 
is 12%, unchanged from 1995 (21). 
M ost pregnancies among contraceptive 
users are caused by inconsistent or 
incorrect use, not by a failure of the 
method itself (22). Further, differences 
(e.g., by Hispanic origin, race, and 
income) between groups in the 
effectiveness of contraceptive use in 
the United States have been 
persistent (21).
•  The leading current method of 
contraception in the United States in 
2006-2008 was the oral contra­
ceptive pill. It was currently being 
used by 10.7 million women aged 
15-44 years. The second leading 
current method of contraception was 
female sterilization, used by 10.3 
million women. The pill and female 
sterilization have been the two 
leading methods in the United States 
since 1982.
•  The typical (most common) pattern 
of contraceptive use in the United 
States is to use the condom at first 
intercourse, the pill to delay the first 
birth, and female sterilization when 
the woman has had all the children 
she wants. But there are wide 
variations in these patterns by the 
woman’s education, race and 
Hispanic origin, and other 
characteristics.
•  Between 2002 and 2006-2008, the 
percentage of women who had ever 
used emergency contraception rose 
from 4% to 10% (5.2 million). In 
addition, the percentage who had 
ever used the contraceptive patch 
rose from 1% to 10% (5.3 million) 
(Table 1).
•  Hispanic, black, and Asian women 
were less likely to have ever used 
the oral contraceptive pill than 
non-Hispanic white women. Black
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women were more likely than white 
women to have used the 3-month 
injectable contraceptive, Depo- 
Provera™ (Table 2 and Figure 2).
•  The proportion of women who used 
a method of contraception at their 
first premarital intercourse increased 
from 56% before 1985, to 76% in 
2000-2004 and 84% in 2005-2008 
(Figure 3). M ost of this increase was 
due to an increase in use of the 
male condom at first premarital 
intercourse, from 34% to 72%.
•  About 62% of the 61.9 million 
women aged 15-44 years were 
currently using contraception (at the 
date of interview) in 2006-2008.
The other 38% were not using 
contraception for a variety of 
reasons. These included women who 
were ‘‘not at risk of unintended 
pregnancy’’ because they were 
currently pregnant or postpartum, 
trying to become pregnant, sterile 
for medical (noncontraceptive) 
reasons, unable to conceive, or had 
not had intercourse recently or ever 
(Table 4 and Figure 4).
•  The 7.3% of women ‘‘at risk of 
unintended pregnancy’’ because they 
had been having intercourse in the 
last 3 months and were not using 
contraception are notable because 
these 4.5 million women account for 
a large proportion of all unintended 
pregnancies; the remaining 
unintended pregnancies occurred to 
the 38.2 million contraceptive users, 
primarily because of inconsistent or 
incorrect contraceptive use 
(14,21,22,29).
•  Non-Hispanic black women were 
more likely to use female 
sterilization as a method of 
contraception than non-Hispanic 
white women, and less likely to rely 
on male sterilization than white 
women (Figure 5). However, 
considering male and female 
sterilization together, about the same 
percentage of white, black, and 
Hispanic women were using 
sterilization: 23% of each group.
•  Among women at risk of unintended 
pregnancy (i.e., excluding women 
who were currently pregnant, trying 
to get pregnant, or sterile for health 
reasons), 9% of Hispanic, white, and
Asian women were not currently 
using contraception compared with 
16% of at-risk black women 
(Table 8 and Figure 6). This finding 
may be related to higher rates of 
unintended pregnancy among black 
women than white women (9).
•  Some of the tables in this report 
show data on contraceptive choice 
among the 38.2 million women 
15-44 years of age who were using 
contraception in 2006-2008 
( ‘‘contraceptors’’). They answered 
the question, ‘‘Of those who are 
using a method, what percentage is 
using each method?’’ These data 
show that female sterilization is the 
leading method among those 30-44 
years of age (Table 10). By age 
40-44 years, 50% of contraceptors 
were using female sterilization 
(Figure 7).
•  The percentage of contraceptors 
using the pill in 2006-2008 ranged 
from 54% at ages 15-19 to 11% of 
contraceptors at ages 40-44 
(Figure 8).
•  More than one-half of childless 
contraceptive users (55%) were 
currently using the pill in 
2006-2008 compared with 8% of 
contraceptors with three or more 
children. Conversely, 2% of 
childless contraceptors and 59% of 
contraceptors with three or more 
children were using female 
sterilization (Figure 9).
•  One noteworthy trend between 2002 
and 2006-2008 was an increase in 
IUD use among women with one or 
two children. IUD use increased 
from 2% to 8% among contraceptors 
with one child, and from 3% to 11% 
of contraceptors with two children 
(Table 10).
•  The proportion of contraceptors 
22-44 years of age who chose 
female sterilization as a method of 
birth control varied by education. 
Female sterilization was used by 
55% of contraceptive users without 
a high school diploma in 2006-2008 
compared with just 16% of 
contraceptors with a 4-year college 
degree (Figure 10).
•  While contraceptors with less 
education tend to rely on female 
sterilization, contraceptors with more
education tend to rely on the oral 
contraceptive pill: just 10% of 
contraceptors without a high school 
diploma used the pill in 2006-2008 
compared with 35% of contraceptors 
with a 4-year college degree 
(Figure 11).
•  This report also shows the extent of 
use of the condom with other 
methods of birth control. About 9% 
of unmarried women had a partner 
who was using male condoms as 
their most effective method of 
contraception in 2006-2008, but 
another 5% were using condoms 
along with a more effective 
method— such as the pill or 
Depo-Provera™— so a total of 14% 
were using the condom. Among 
married women, however, this kind 
of combination use was much less 
common (Figure 12).
•  Among women who stopped using 
the pill, injectable, and patch, most 
stopped because of side effects that 
they attributed to the method. A 
variety of other reasons were also 
offered. Among those who stopped 
using the condom, the leading 
reasons for stopping were that the 
woman’s male partner did not like 
it, it decreased the woman’s sexual 
pleasure, and fear that the method 
would not work (Table 15).
•  The international comparisons 
shown in Table F show that in some 
European countries with lower birth 
and abortion rates than in the United 
States (30-33), there is greater 
reliance on the pill and IUD and 
lower use of sterilization. However, 
the data do not show the specific 
causes of those differences.
The explanation of the patterns of 
contraceptive use in the United States 
and internationally is beyond the scope 
of this report, but these observations and 
the references cited here (14,29,33-35) 
suggest that further research may yield 
insights that could improve contra­
ceptive method choice and use in the 
United States in the years ahead, 
particularly for those groups in which 
rates of unintended pregnancy are 
especially high.
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Table 1. Number of women aged 15-44 years who have ever had sexual intercourse and percentage who have ever used the specified
contraceptive method: United States, 1982, 1995, 2002, and 2006-2008
Method 1982 1995 2002 2006-2008
Number in thousands
All women............................................................................. 46,684 53,800 54,190 53,240
Percent (standard error) who have ever used specified method
Any method........................................................................... . 94.8 (0.4) 98.2 (0.2) 98.2 (0.2) 99.1 (0.2)
Female sterilization............................................................. . 22.3 (0.8) 23.4 (0.5) 20.7 (0.7) 19.9 ( 1.1)
Male sterilization.................................................................. . 10.1 (0.6) 14.6 (0.4) 13.0 (0.7) 13.4 (0.8)
P i l l ........................................................................................ . 76.3 (0.8) 82.2 (0.5) 82.3 (0.6) 82.3 ( 1.1)
Norplant™ or Implanon™ im p lan t.................................... . - - - 2.1 (0.2) 2.1 (0.2) 1.4 (0.3)
1-month injectable (Lunelle™ ).......................................... . - - - - - _ 0.9 (0.1) 1.9 (0.5)
3-month injectable (Depo-Provera™).............................. . - - - 4.5 (0.2) 16.8 (0.8) 22.2 ( 1.1)
Emergency contraception.................................................. . - - - 0.8 (0.1) 4.2 (0.3) 9.7 (0.7)
Contraceptive patch............................................................. . - - - - - _ 0.9 (0.1) 10.0 (0.7)
Contraceptive ring ............................................................. . - - - - - - - - _ 6.3 (0.6)
Today™ sponge.................................................................. . - - - 12.0 (0.4) 7.3 (0.4) 4.7 (0.5)
Intrauterine device (IUD).................................................... . 18.4 (0.8) 10.0 (0.4) 5.8 (0.4) 7.4 (0.7)
D iaphragm ........................................................................... . 17.1 (0.8) 15.2 (0.5) 8.5 (0.5) 3.1 (0.4)
Condom................................................................................ . 51.8(1.0) 82.0 (0.5) 89.7 (0.6) 93.0 (0.6)
Female condom .................................................................. . - - - 1.2 (0.1) 1.9 (0.2) 1.9 (0.3)
Periodic abstinence—calendar rh y th m ............................ . 17.0 (0.8) 24.3 (0.5) 16.2 (0.6) 19.4 (1.1)
Periodic abstinence— natural family p lan n ing ................. . 2.3 (0.3) 4.2 (0.3) 3.5 (0.3) 4.6 (0.5)
W ithdraw al........................................................................... . 24.5 (0.8) 40.6 (0.6) 56.1 (1.0) 58.8 (1.4)
Foam alone........................................................................... . 24.9 (0.8) 18.3 (0.5) 12.1 (0.4) 6.6 (0.5)
Jelly or cream a lo n e .......................................................... . 5.8 (0.4) 9.1 (0.3) 7.3 (0.4) 4.7 (0.6)
Suppository or in se rt.......................................................... . 9.7 (0.6) 10.6 (0.3) 7.5 (0.5) 3.4 (0.4)
Other methods1 .................................................................. 9.3 (0.6) 0.3 (0.1) 1.0 (0.1) 0.8 (0.2)
—  Data not availab le  (m ethod not available in the  United S tates in that year).
1Includes the  cervical cap and o ther methods.
NOTE: Percentages (standard errors) fo r 1982, 1995, and 2002 are from  M osher et al., 2004, Table 1.
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Table 2. Number of women aged 15-44 years who have ever had sexual intercourse and percentage who have ever used the specified

















All women........................................................................... 9,169 32,152 7,309 4,611 2,094
Percent (standard error) who have ever used specified method
Any method........................................................................ . . 97.2(1.0) 99.7 (0.1) 99.0 (0.5) 98.5 (0.4) 98.6 (0.7)
Female sterilization.......................................................... . . 23.1 (2.9) 17.7 ( 1.3) 25.8 (2.1) 18.8 (4.7) 13.9 (7.6)
Male sterilization................................................................ . . 6.6 (1.2) 18.1 ( 1.0) 4.8 (1.1) 8.6 (2.6) 5.4 (3.0)
P i l l ...................................................................................... . . 68.2(1.9) 88.8 (0.9) 78.4 (2.1) 71.3 (4.1) 56.4 (6.8)
Norplant™ or Implanon™ im p lan t................................. . . 0.8 (0.3) 1.4 (0.4) 1.7 (0.5) 2.1 (0.9) *
1-month injectable (Lunelle™ )....................................... . . 7.4 (2.0) 0.7 (0.2) 0.6 (0.2) 1.6 ( 1.0) *
3-month injectable (Depo-Provera™)............................ . . 26.2(2.4) 19.0 (1.2) 29.5 (1.8) 25.3 (4.4) 16.6 (7.3)
Emergency contraception............................................... . . 11.0(1.3) 9.8 (0.9) 6.5 (0.9) 11.7 (2.8) 14.2 (4.8)
Contraceptive patch.......................................................... . . 9.6 (2.0) 9.2 (0.8) 14.4 (1.5) 8.9 (2.2) 4.4 (2.2)
Contraceptive ring .......................................................... . . 5.0 (1.1) 6.7 (0.8) 6.5 (1.1) 5.7 (2.2) 8.6 (4.6)
Today™ sponge................................................................ . . 1.4 (0.4) 6.5 (0.7) 2.4 (0.5) 2.2 (1.1) -
Intrauterine device (IUD).................................................. . . 14.0(1.2) 6.3 (1.0) 5.5 (1.2) 5.0 (1.4) 2.6 (0.9)
D iaphragm ........................................................................ . . 1.6 (0.6) 3.7 (0.5) 2.5 (0.5) 3.1 (1.3) 4.0 (2.4)
Condom............................................................................. . . 80.5(1.9) 96.4 (0.6) 94.9 (1.4) 90.7 (2.3) 89.4 (3.0)
Female condom ................................................................ . . 2.1 (0.7) 1.1 (0.3) 4.8 (1.0) 2.4 (1.3) *
Periodic abstinence—calendar rh y th m ......................... . . 16.6(1.6) 19.3 (1.5) 18.2 (1.5) 28.2 (4.7) 42.1 (7.4)
Periodic abstinence— natural family p lan n ing .............. . . 3.4 (0.9) 4.5 (0.6) 2.5 (0.6) 10.5 (4.0) 17.6 (7.8)
W ithdraw al........................................................................ . . 52.6 (2.2) 62.0 (2.0) 56.7 (2.4) 51.8 (5.1) 49.6 (6.3)
Foam alone........................................................................ . . 3.4 (0.6) 7.8 (0.7) 8.0 (1.1) 3.0 (1.1) *
Jelly or cream a lo n e ....................................................... . . 2.3 (0.7) 5.7 (0.8) 5.2 (1.2) 1.8 (0.8) *
Suppository or in s e r t....................................................... . . 2.7 (0.6) 3.5 (0.5) 4.8 (1.0) 2.3 (1.4) *
Other methods1 ............................................................... . . 1.1 (0.3) * * *
* F igure does not meet standard of reliability or precision. 
-  Q uantity zero.
'’ Includes the  cervical cap and o ther methods.
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Table 3. Number of women aged 15-44 years whose first premarital sexual intercourse was after menarche, and percentage who used the












All women1 ............................................................................. 47,145 69.7 (1.21) 18.0 (0.88) 53.6 (1.26) 6.3 (0.60) 3.0 (0.35)
Year of first sexual intercourse after menarche
2005-2008 ............................................................................. 4,615 84.1 (2.66) 19.2 (2.43) 71.5 (3.84) 9.0 (1.88) 6.9 (2.00)
2000-2004 ............................................................................. 8,461 75.8 (2.21) 20.2 (1.90) 63.5 (2.46) 3.0 (0.64) 3.5 (0.74)
1995-1999 ............................................................................. 8,051 72.5 (2.12) 20.3 (2.08) 58.0 (2.46) 5.9 (1.01) 2.2 (0.56)
1990-1994 ............................................................................. 8,615 69.7 (2.67) 17.9 (1.88) 54.8 (2.48) 5.2 (1.09) 2.9 (0.69)
1985-1989 ............................................................................. 9,504 66.0 (2.82) 15.1 (1.76) 47.5 (3.00) 7.5 (1.62) 2.5 (0.94)
Before 1985 ........................................................................... 7,899 56.3 (2.73) 16.4 (2.01) 34.0 (2.73) 8.6 (1.43) 1.9 (0.58)
Age at first sexual intercourse after menarche
Under 16 y e a rs ..................................................................... 12,880 63.9 (1.93) 10.7 (1.24) 51.5 (2.02) 6.6 (1.14) 2.9 (0.56)
16-17 y e a rs ........................................................................... 16,673 69.8 (1.57) 17.8 (1.64) 57.0 (1.95) 4.8 (0.57) 2.1 ( 0.40)
18-19 y e a rs ........................................................................... 10,460 74.8 (2.24) 22.5 (1.82) 53.5 (2.55) 8.3 (1.35) 4.3 ( 1.04)
20 years or o ld e r .................................................................. 7,132 72.3 (3.82) 25.1 (2.86) 49.6 (3.57) 6.6 (1.82) 3.4 ( 1.07)
Mother's education2
No high school diploma or G E D ......................................... 10,883 52.8 (3.20) 13.1 (2.05) 37.1 (2.62) 5.7 (1.11) 2.9 (0.61)
High school diploma or G E D ............................................... 15,988 69.3 (1.67) 17.8 (1.23) 53.0 (1.76) 7.0 (1.02) 3.1 (0.71)
Some college, no bachelor's d e g re e ................................. 10,759 75.5 (2.04) 22.5 (1.81) 59.4 (2.87) 5.8 (1.06) 2.6 (0.66)
Bachelor's degree or higher.................................................. 9,213 83.9 (1.84) 19.3 (2.03) 67.8 (2.49) 6.3 (0.88) 3.6 (0.94)
Race and Hispanic origin
Hispanic................................................................................... 7,541 51.5 (3.31) 10.6 (1.61) 37.9 (2.74) 6.0 (1.08) 1.7 (0.50)
Non-Hispanic:
White, single r a c e ............................................................. 29,011 76.4 (1.34) 20.2 (1.10) 59.3 (1.64) 6.8 (0.80) 3.1 (0.51)
Black, single race ............................................................. 6,762 64.8 (1.80) 20.9 (2.08) 49.3 (2.12) 5.6 (1.12) 2.1 (0.35)
All other single race and multiple ra ce ............................ 3,830 63.0 (6.55) 11.3 (2.00) 48.7 (6.92) 4.8 (1.50) 6.3 (1.59)
Year of first sexual intercourse after menarche and 
race and Hispanic origin
First sexual intercourse after menarche before 2000. . . . 34,069 66.2 (1.45) 17.3 (1.05) 48.7 (1.44) 6.8 (0.71) 2.4 (0.33)
H ispan ic ............................................................................. 5,013 45.4 (3.59) 9.4 (2.06) 30.6 (2.81) 5.9 (1.42) 1.9 (0.87)
Non-Hispanic:
White, single ra c e .......................................................... 21,490 73.4 (1.57) 18.5 (1.22) 55.4 (1.79) 7.5 (0.94) 2.3 (0.39)
Black, single ra c e .......................................................... 4,876 61.0 (2.14) 23.8 (2.60) 41.7 (2.48) 6.5 (1.31) 1.5 (0.42)
First sexual intercourse after menarche in 2000 and
later........................................................................................ 13,076 78.7 (1.53) 19.9 (1.36) 66.3 (1.98) 5.1 (0.80) 4.7 (0.90)
H ispan ic ............................................................................. 2,528 63.6 (3.67) 13.1 (2.29) 52.3 (3.55) 6.2 (1.80) 1.1 (0.59)
Non-Hispanic:
White, single ra c e .......................................................... 7,521 85.0 (1.90) 24.8 (2.19) 70.3 (2.62) 5.0 (1.02) 5.6 (1.40)
Black, single ra c e .......................................................... 1,887 74.5 (3.52) 13.2 (2.97) 68.9 (3.66) 3.1 (1.76) 3.8 (0.88)
1Includes women with missing information on date of first sex after menarche, with no mother or mother-figure, and whose m other-figures had no biological children. 
2G ED is General Educational Developm ent high school equ iva lency diploma.
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Table 4. Number of women aged 15-44 years and percent distribution by current contraceptive status and method: United States,
1982-2008
Contraceptive status and method
Year of survey
1982 1995 2002 2006-2008
Number in thousands
All women.................................................................................................... 54,099 60,201 61,561 61,864
Percent distribution (standard error)
Total ............................................................................................................ 100.0 100.0 100.0 100.0
Using contraception (contraceptors)....................................................... 55.7 ( 1.0) 64.2 (0.6) 61.9 (0.8) 61.8 (1.2)
Female sterilization................................................................................ 12.9 (0.6) 17.8 (0.4) 16.7 (0.6) 16.7 ( 1.0)
Male s te riliza tion ................................................................................... 6.1 (0.4) 7.0 (0.3) 5.7 (0.4) 6.1 (0.5)
P i l l ............................................................................................................ 15.6 (0.8) 17.3 (0.4) 18.9 (0.7) 17.3 (0.8)
Implant, Lunelle™, or patch1 ................................................................ - - - 0.9 (0.1) 0.8 (0.1) 0.7 (0.1)
3-month injectable (Depo-Provera™).................................................. - - - 1.9 (0.1) 3.3 (0.3) 2.0 (0.2)
Contraceptive r in g ................................................................................ - - - - - - - - - 1.5 (0.2)
Intrauterine device (IUD)........................................................................ 4.0 (0.4) 0.5 (0.1) 1.3 (0.2) 3.4 (0.5)
D iaphragm.............................................................................................. 4.5 (0.4) 1.2 (0.1) 0.2 (0.1) *
Condom.................................................................................................... 6.7 (0.6) 13.1 (0.4) 11.1 (0.5) 10.0 (0.6)
Periodic abstinence—calendar rhy thm ............................................... 1.8 (0.3) 1.3 (0.1) 0.7 (0.1) 0.5 (0.1)
Periodic abstinence—natural family p lann ing .................................... 0.3 (0.3) 0.2 (0.1) 0.2 (0.1) 0.1 (0.1)
W ithdrawal.............................................................................................. 1.1 (0.3) 2.0 (0.2) 2.5 (0.3) 3.2 (0.3)
Other methods2 ...................................................................................... 2.7 (0.3) 1.1 (0.1) 0.6 (0.1) 0.2 (0.1)
Not using con traception ........................................................................... 44.3 ( 1.0) 35.8 (0.6) 38.1 (0.8) 38.2 ( 1.2)
Surgically sterile—female (noncontraceptive).................................... 6.3 (0.4) 3.0 (0.2) 1.5 (0.2) 0.4 (0.1)
Nonsurgically sterile—female or male.................................................. 1.2 (0.3) 1.7 (0.2) 1.6 (0.2) 1.7 (0.3)
Pregnant or postpartum ........................................................................ 5.0 (0.3) 4.6 (0.3) 5.3 (0.4) 5.4 ( 0.4)
Seeking pregnancy................................................................................ 4.2 (0.4) 4.0 (0.2) 4.2 (0.3) 4.1 (0.3)
Other nonuse:
Never had intercourse or no intercourse in 3 months before
in te rv iew ........................................................................................... 19.5 (0.8) 17.1 (0.5) 18.1 (0.7) 19.2 ( 1.2)
Had intercourse in 3 months before in te rv iew .............................. 7.4 ( 0.4) 5.2 (0.2) 7.4 ( 0.4) 7.3 (0.6)
All other nonuse3................................................................................ 0.7 (0.3) 0.2 (0.0) 0.0 (0.0) *
—  Data not available (m ethod not availab le  in the United S tates in that year).
* F igure does not meet standard of reliability or precision.
0.0 Q uantity greater than 0 but less than 0.05.
11995 percentage only includes Norplant™  implant.
2Includes em ergency contraception, fem ale  condom  or vaginal pouch, foam, cervical cap, Today™ sponge, suppository or insert, je lly  or cream  (w ithout d iaphragm ), and other methods. 
3Includes male s terility  of unknown origin and other sm all groups, not shown separately
NOTE: Percentages may not add to  100 due to  rounding. Percentages (standard errors) fo r 1982, 1995, and 2002 are from  M osher et al., 2004, Table 4.
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Table 5. Number of women aged 15-44 years and percent distribution by current contraceptive status and method, according to age at
interview: United States, 2006-2008
Age in years
Contraceptive status and method 15-44 15-19 20-24 25-29 30-34 35-39 40-44
All w o m e n ........................................................................ 61,864 10,431
Number in thousands 
10,140 10,250 9,587 10,475 10,982
Total................................................................................... 100.0 100.0
Percent distribution (standard error) 
100.0 100.0 100.0 100.0 100.0
Using contraception (contraceptors)............................ 61.8 (1.21) 28.2 (1.91) 54.7 (2.81) 64.2 (1.85) 70.3 (2.32) 75.0 (2.23) 77.8 (1.75)
Female steriliza tion.................................................... 16.7 (0.96) * 1.3 (0.41) 9.6 (1.13) 20.6 (2.35) 28.2 (2.39) 39.1 (2.67)
Male sterilization.......................................................... 6.1 (0.53) - 0.4 (0.16) 2.1 (0.53) 5.8 (0.97) 12.4 (1.71) 15.3 (2.33)
P i l l ................................................................................ 17.3 (0.83) 15.2 ( 1.54) 26.2 (2.02) 22.6 (1.79) 17.4 ( 1.79) 14.4 ( 1.81) 8.6 (1.55)
Implant, Lunelle™, or p a tch ....................................... 0.7 (0.12) 0.5 (0.20) 0.8 (0.22) 1.3 (0.39) 0.9 (0.44) 0.3 (0.14) *
3-month injectable (Depo-Provera™ )...................... 2.0 (0.24) 2.6 (0.49) 2.8 (0.64) 3.3 (0.65) 1.6 (0.36) 0.7 (0.34) 0.9 (0.32)
Contraceptive r in g ....................................................... 1.5 (0.22) 1.0 (0.51) 3.4 (0.96) 2.0 (0.46) 1.7 (0.61) 0.7 (0.33) 0.3 (0.14)
Intrauterine device (IU D )............................................ 3.4 (0.52) 1.0 (0.58) 3.2 (0.70) 4.0 (0.74) 4.7 (1.19) 4.4 (1.57) 3.2 (0.89)
C ondom ........................................................................ 10.0 (0.63) 6.4 (0.71) 13.4 (1.29) 13.1 (1.33) 12.0 (1.71) 8.4 (1.50) 6.8 (1.19)
Periodic abstinence—calendar rhythm...................... 0.5 (0.10) * 0.2 (0.09) 0.7 (0.39) 0.7 (0.28) 0.9 (0.40) 0.5 (0.24)
Periodic abstinence— natural family planning . . . . 0.1 (0.06) - - - 0.6 (0.33) * *
W ithd raw a l.................................................................. 3.2 (0.33) 1.1 (0.27) 2.8 (0.62) 5.1 (0.82) 3.7 (0.80) 4.3 (1.27) 2.5 (0.75)
Other methods1 .......................................................... 0.3 (0.09) * * 0.4 (0.16) 0.7 (0.38) * *
Not using contraception.................................................. 38.2 (1.21) 71.8 (1.91) 45.3 (2.81) 35.8 (1.85) 29.7 (2.32) 25.0 (2.23) 22.2 (1.75)
Surgically sterile—female (noncontraceptive) . . . . 0.4 (0.13) - - * * 0.4 (0.23) 1.7 (0.68)
Nonsurgically sterile—female or m a le ...................... 1.7 (0.28) 0.5 (0.24) 1.5 (0.47) 2.6 (1.15) 1.6 (0.49) 2.2 (0.63) 1.8 (0.38)
Pregnant or po s tpa rtum ............................................ 5.4 (0.37) 3.9 (0.52) 10.0 (1.52) 7.7 (1.27) 8.1 (1.73) 1.9 (0.42) 1.7 (0.57)
Seeking pregnancy.................................................... 4.1 (0.30) 0.9 (0.48) 4.3 (1.02) 6.3 (1.11) 5.9 (1.18) 5.1 (0.89) 2.5 (0.63)
Other nonuse:
Never had intercourse or no intercourse in 
3 months before interview.................................... 19.2 (1.22) 60.0 (2.12) 20.4 (3.08) 10.6 (1.28) 8.7 (1.14) 7.4 (1.12) 8.0 (1.11)
Had intercourse in 3 months before interview . . . 7.3 (0.58) 6.5 (0.84) 9.1 (1.49) 8.6 (1.32) 5.3 (0.78) 8.0 (1.33) 6.4 (1.23)
* F igure does not meet standard of reliability or precision.
-  Q uantity zero.
1Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervical cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
d iaphragm ), and other methods.
NOTE: Percentages may not add to  100 due to  rounding.
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Table 6. Number of women aged 15-44 years and percent distribution by current contraceptive status and specific method, according to
race and Hispanic origin: United States, 2006-2008






Other single race or multiple race
Total other 
single race
or multiple Asian 
race only
Number in thousands
All w o m e n ..................................................................... 61,864 10,377 37,660 8,452 5,375 2,493
Percent distribution (standard error)
Total................................................................................ 100.0 100.0 100.0 100.0 100.0 100.0
Using contraception (contraceptors)......................... . 61.8 ( 1.21) 58.5 (1.90) 64.7 (1.59) 54.5 (2.54) 59.2 (3.00) 63.9 (4.67)
Female steriliza tion.................................................. . 16.7(0.96) 19.6 (2.09) 14.9 ( 1.22) 21.8 (1.89) 16.1 (3.70) 11.6 (6.45)
Male sterilization....................................................... . 6.1 (0.53) 3.4 (0.91) 8.3 (0.71) 1.1 (0.42) 3.9 (1.73) 4.5 (2.58)
P i l l ............................................................................. . 17.3(0.83) 11.4 (1.53) 21.2 ( 1.11) 11.4 (1.13) 10.9 (1.88) 11.1 (2.33)
Implant, Lunelle™, or p a tch .................................... . 0.7(0.12) 1.5 (0.43) 0.5 (0.09) 0.6 (0.16) 1.0 (0.55) -
3-month injectable (Depo-Provera™ )................... . 2.0 (0.24) 2.6 (0.52) 1.4 (0.20) 4.1 (0.84) 1.8 (0.52) *
Contraceptive r in g .................................................... . 1.5 (0.22) 1.2 (0.42) 1.6 (0.33) 1.7 (0.69) 0.8 (0.31) *
Intrauterine device (IU D )......................................... . 3.4 (0.52) 4.8 (0.77) 3.3 (0.67) 2.8 (0.95) 2.2 (0.46) 1.9 (0.74)
C ondom ..................................................................... . 10.0(0.63) 9.4 (0.98) 9.5 (0.78) 8.8 (1.30) 16.2 (3.16) 26.1 (5.48)
Periodic abstinence—calendar rhythm................... . 0.5(0.10) 0.6 (0.33) 0.5 (0.13) * 1.0 (0.52) 2.1 (1.08)
Periodic abstinence— natural family planning . . . . 0.1 (0.06) * * * * *
W ithd raw a l................................................................ . 3.2 (0.33) 3.0 (0.47) 3.3 (0.49) 2.1 (0.47) 5.1 (1.23) 4.8 (1.61)
Other methods1 ....................................................... 0.3 (0.09) 0.5 (0.35) 0.3 (0.07) * * *
Not using contraception............................................... . 38.2(1.21) 41.5 (1.90) 35.3 (1.59) 45.5 (2.54) 40.8 (3.00) 36.1 (4.67)
Surgically sterile—female (noncontraceptive) . . . . 0.4(0.13) 0.7 (0.47) 0.2 (0.09) 0.4 (0.28) * -
Nonsurgically sterile—female or m a le ................... . 1.7(0.28) 1.8 (0.47) 1.6 (0.39) 1.8 (0.55) 1.9 (0.62) 1.2 (0.81)
Pregnant or po s tpa rtum ......................................... . 5.4 (0.37) 8.3 (1.24) 4.9 (0.54) 5.7 (0.81) 3.4 (0.91) 2.9 (1.19)
Seeking pregnancy.................................................. . 4.1 (0.30) 6.2 (1.26) 3.5 (0.33) 4.4 (0.79) 4.1 (0.93) 3.0 (1.13)
Other nonuse:
Never had intercourse or no intercourse in
3 months before interview................................. . 19.2 ( 1.22) 18.8 (1.35) 18.3 (1.63) 22.6 (2.02) 21.2 (2.81) 23.1 (4.01)
Had intercourse in 3 months before
interview............................................................... 7.3 (0.58) 5.8 (0.86) 6.7 (0.69) 10.6 (1.18) 9.5 (1.69) 5.9 (2.74)
-  Q uantity zero.
* F igure does not meet standard of reliability or precision.
1Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervical cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
diaphragm ), and other methods.
NOTE: Percentages may not add to  100 due to  rounding.
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Table 7. Number of women aged 15-44 years and percent distribution by current contraceptive status and specific method, according to




Marital and cohabitation status









Number of women in thousands......................................... 61,864 27,006 6,821 5,190 22,847
Total ........................................................................................ 100.0
Percent distribution (standard error) 
100.0 100.0 100.0 100.0
Using contraception (contraceptors).................................... 61.8 (1.21) 78.6 (1.25) 71.2 (2.07) 60.6 (2.80) 39.3 (2.31)
Female sterilization............................................................. 16.7 (0.96) 23.6 (1.82) 16.3 (2.11) 35.3 (2.96) 4.5 (0.69)
Male steriliza tion............................................................... 6.1 (0.53) 12.7 (1.14) 2.2 (0.63) 2.3 (0.71) 0.3 (0.11)
P ill........................................................................................ 17.3 (0.83) 16.3 (1.46) 23.2 (2.42) 11.4 (1.88) 18.1 (1.44)
Implant, Lunelle™, or p a tc h ............................................ 0.7 (0.12) 0.7 (0.20) 1.0 (0.36) * 0.6 (0.16)
3-month injectable (Depo-Provera™).............................. 2.0 (0.24) 1.4 (0.32) 3.1 (0.61) 2.6 (0.64) 2.2 (0.30)
Contraceptive r in g ............................................................. 1.5 (0.22) 1.0 (0.25) 3.7 (1.25) 0.8 (0.30) 1.5 (0.39)
Intrauterine device ( IU D ) .................................................. 3.4 (0.52) 5.3 (0.85) 4.7 (1.51) 2.1 (0.87) 1.1 (0.33)
C o n d o m ............................................................................. 10.0 (0.63) 11.7 (1.03) 10.2 (1.41) 4.1 (0.86) 9.1 (0.81)
Periodic abstinence—calendar rhythm ............................ 0.5 (0.10) 1.0 (0.23) 0.4 (0.22) * 0.2 (0.09)
Periodic abstinence—natural family planning................. 0.1 (0.06) 0.2 (0.07) * * *
W ithdrawal........................................................................... 3.2 (0.33) 4.5 (0.69) 5.3 (0.96) 1.4 (0.55) 1.5 (0.29)
Other methods1 .................................................................. 0.3 (0.09) 0.3 (0.10) * * 0.2 (0.07)
Not using contraception....................................................... 38.2 (1.21) 21.4 (1.25) 28.8 (2.07) 39.4 (2.80) 60.7 (2.31)
Surgically sterile—female (noncontraceptive)................. 0.4 (0.13) 0.3 (0.13) * 1.0 (0.41) 0.4 (0.25)
Nonsurgically sterile—female or m a le ............................ 1.7 (0.28) 1.0 (0.22) 2.2 (0.79) 2.7 (0.86) 2.1 (0.61)
Pregnant or postpartum.................................................... 5.4 (0.37) 7.2 (0.85) 10.5 (1.63) 2.6 (0.83) 2.6 (0.31)
Seeking pregnancy............................................................. 4.1 (0.30) 6.4 (0.52) 7.1 (1.30) 0.8 (0.37) 1.3 (0.37)
Other nonuse:
Never had intercourse or no intercourse in 3 months 
before i nterview............................................................. 19.2 (1.22) 0.9 (0.20) 1.8 (0.65) 21.1 (2.55) 45.6 (2.58)
Had intercourse in 3 months before interview ........... 7.3 (0.58) 5.5 (0.63) 6.9 (1.23) 11.3 (2.57) 8.7 (1.03)
* F igure does not meet standard of reliability or precision.
1Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervica l cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
diaphragm ), and other methods.
NOTE: Percentages may not add to  100 due to  rounding.
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Table 8. Number of women aged 15-44 years, number at risk of unintended pregnancy, and percentage of women currently using a method
of contraception, by selected characteristics: United States, 2006-2008
Characteristic

























All women2 ....................................................... 61,864 61.8 (1.21) 42,756 89.4 (0.76) 10.6 (0.76)
Age
15-19 y e a rs ..................................................... . 10,431 28.2 (1.91) 3,618 81.3 (2.18) 18.7 (2.18)
20-24 y e a rs .................................................... . 10,140 54.7 (2.81) 6,475 85.7 (193) 14.3 (193)
25-29 y e a rs ..................................................... . 10,250 64.2 (1.85) 7,468 88.2 (165) 11.9 (165)
30-34 y e a rs .................................................... . 9,587 70.3 (2.32) 7,245 93.0 (107) 7.0 (107)
35-39 y e a rs ..................................................... . 10,475 75.0 (2.23) 8,701 90.3 (163) 9.7 (163)
40-44 y e a rs ..................................................... 10,982 77.8 (1.75) 9,251 92.4 (145) 7.6 (145)
Marital or cohabiting status
Currently m arried............................................ . 27,006 78.6 (1.25) 22,730 93.4 (0.76) 6.6 (0.76)
Currently coh ab iting ....................................... . 6,821 71.2 (2.07) 5,329 91.1 (155) 8.9 (155)
Formerly married, not co h a b itin g ................ . 5,190 60.6 (2.80) 3,730 84.3 (3.40) 15.7 (3.40)
Never married, not cohab iting ...................... 22,847 39.3 (2.31) 10,967 81.9 (171) 18.1 (171)
Parity
0 b ir th s ............................................................. . 26,882 44.3 (1.95) 13,860 86.0 (136) 14.0 (136)
1 b ir th ................................................................ . 10,350 59.5 (2.26) 7,305 84.4 (2.14) 15.6 (2.14)
2 b ir th s ............................................................. . 12,843 81.7 (1.20) 11,287 92.9 (0.99) 7.1 (0.99)
3 or more b irths ............................................... 11,789 81.8 (1.79) 10,305 93.6 (126) 6.4 (126)
Education3
No high school diploma or G E D ................... . 6,210 67.1 (2.44) 4,731 89.1 (189) 11.9 (189)
High school diploma or G E D ......................... . 11,793 73.5 (1.80) 9,557 90.7 (136) 9.3 (136)
Some college, no bachelor’s d e g re e ........... . 13,537 68.9 (2.21) 10,260 90.9 (150) 9.1 (150)
Bachelor’s degree or h ig h e r ......................... 15,543 70.5 (1.80) 11,942 91.8 (113) 8.2 (113)
Poverty level income4
0% -149%.......................................................... . 16,109 61.7 (1.65) 11,331 87.7 (156) 12.3 (156)
0% -99 % ....................................................... . 10,407 59.5 (2.26) 7,084 87.4 (178) 12.6 (178)
150% -299% .................................................... . 15,360 70.3 (2.21) 12,035 89.7 (127) 10.3 (127)
300% or m o re .................................................. 19,965 72.8 (1.51) 15,773 92.1 (0.88) 7.9 (0.88)
Intent to have more children
Intends more.................................................... . 30,148 47.3 (1.68) 16,697 85.4 (139) 14.6 (139)
Intends no more............................................... 30,866 75.8 (1.08) 25,462 91.8 (0.83) 8.2 (0.83)
Race and Hispanic origin
Hispanic............................................................. . 10,377 58.5 (1.90) 6,669 91.1 (124) 9.0 (124)
Non-Hispanic:
White, single ra c e ....................................... . 37,660 64.7 (1.59) 26,889 90.6 (0.92) 9.4 (0.92)
Black, single r a c e ....................................... . 8,452 54.5 (2.54) 5,504 83.7 (186) 16.3 (186)
All other single race and multiple race . . . . 5,375 59.2 (3.00) 3,694 86.2 (2.39) 13.8 (2.39)
Asian, single race ................................. 2,493 63.9 (4.67) 1,739 91.5 (3.85) 8.5 (3.85)
1‘‘At risk of unintended p regnancy’’ is defined as codes 1 -22  and 42 on CONSTAT1, the  recode fo r current contraceptive  status. These codes represent all current contraceptors plus wom en who have 
had sex in the  last 3 months but are not current contraceptors.
2Includes women who do not know whether they intend to  have more children, not shown separately.
3Lim ited to  women 2 2 -4 4  years of age at tim e of interview.
4Lim ited to  women 2 0 -4 4  years of age at tim e of interview.
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Table 9. Number of women aged 15-44 years currently using contraception, and percent distribution by current contraceptive method:
United States, 1982-2008
Contraceptive status and method
Year of survey
1982 1995 2002 2006-2008
Number in thousands
All women using contraception....................................................... 30,142 38,663 38,109 38,214
Percent distribution (standard error)
Using contraception (contraceptors)............................................... . . . 100.0 100.0 100.0 100.0
Female sterilization........................................................................ . . . 23.2 (0.8) 27.8 (0.6) 27.0 (0.9) 27.1 ( 1.5)
Male s te riliza tion ........................................................................... . . . 10.9 (0.6) 10.9 (0.4) 9.2 (0.6) 9.9 (0.8)
P i l l .................................................................................................... . . . 28.0 (0.9) 26.9 (0.6) 30.6 (0.9) 28.0 ( 1.3)
Implant, Lunelle™, or patch1 .................................................... . . . - - - 1.3 (0.2) 1.2 (0.2) 1.1 (0.2)
3-month injectable (Depo-Provera™)......................................... . . .  - - - 3.0 (0.2) 5.3 (0.5) 3.2 (0.4)
Contraceptive r in g ........................................................................ . . . - - - - - - - - - 2.4 ( 0.4)
Intrauterine device (IUD)................................................................ . . . 7.1 (0.4) 0.8 (0.1) 2.0 (0.3) 5.5 (0.8)
D iaphragm...................................................................................... . . . 8.1 (0.6) 1.9 (0.2) 0.3 (0.1) *
Condom........................................................................................... . . . 12.0(0.6) 20.4 (0.5) 18.0 (0.7) 16.1 (0.9)
Periodic abstinence—calendar rh y thm ....................................... . . . 3.3 (0.4) 2.0 (0.2) 1.2 (0.2) 0.9 (0.2)
Periodic abstinence— natural family p lann ing ............................ . . . 0.6 (0.3) 0.3 (0.1) 0.4 (0.1) 0.2 (0.1)
W ithdrawal...................................................................................... . . . 2.0 (0.3) 3.1 (0.2) 4.0 (0.4) 5.2 (0.5)
Other methods2 ............................................................................. 1.3 (0.3) 1.7 (0.2) 0.9 (0.2) 0.4 (0.1)
—  Data not available (m ethod not availab le  in the United S tates in that year).
* F igure does not meet standards of re liability or precision.
11995 percentage only includes Norplant™  implant.
2Includes em ergency contraception, fem ale  condom  or vaginal pouch, foam, cervical cap, Today™ sponge, suppository or insert, je lly  or cream  (w ithout d iaphragm ), and other methods. 
NOTE: Percents m ay not add to  100 due to  rounding. Percentages (standard errors) fo r 1982, 1995, and 2002 are from  M osher et al., 2004, Table 5.
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Table 10. Number of women aged 15-44 years who are currently using a method of contraception and percent distribution by method,







method Female Male Pill Condom IUD
Percent distribution
All women1
2006-2008.................................................. . 38,214 100.0 27.1 9.9 28.0 16.1 3.2 5.5 10.2
2002 .......................................................... 38,109 100.0 27.0 9.2 30.6 18.0 5.3 2.0 7.9
Age
2006-2008:
15-19 y e a rs .......................................... . 2,941 100.0 * - 54.1 22.8 9.4 3.6 10.1
20-24 y e a rs ......................................... . 5,548 100.0 2.4 0.7 48.0 24.5 5.1 5.9 13.4
25-29 y e a rs .......................................... . 6,583 100.0 15.0 3.3 35.1 20.5 5.2 6.2 14.7
30-34 y e a rs ......................................... . 6,737 100.0 29.3 8.3 24.8 17.1 2.2 6.6 11.7
35-39 y e a rs .......................................... . 7,859 100.0 37.6 16.5 19.3 11.2 1.0 5.8 8.6
40-44 y e a rs .......................................... . 8,547 100.0 50.2 19.6 11.1 .88. 1.1 4.2 5.1
2002:
15-19 y e a rs .......................................... . 3,096 100.0 - - 52.8 27.0 13.9 * 6.0
20-24 y e a rs ......................................... . 5,975 100.0 3.6 0.8 52.3 23.1 10.1 1.8 8.3
25-29 y e a rs .......................................... . 6,291 100.0 15.1 4.2 37.6 20.5 6.5 3.7 12.4
30-34 y e a rs ......................................... . 7,105 100.0 27.5 9.2 31.5 17.1 4.2 3.1 7.5
35-39 y e a rs .......................................... . 7,688 100.0 41.2 14.2 18.6 15.7 2.1 1.5 6.8
40-44 y e a rs .......................................... 7,955 100.0 50.3 18.4 10.9 11.5 1.6 1.1 6.2
Marital or cohabiting status 
2006-2008:
Currently m a rried ................................. . 21,238 100.0 30.0 16.2 20.7 14.9 1.7 6.7 9.8
Currently cohabiting.............................. . 4,855 100.0 22.9 3.2 32.5 14.3 4.4 6.6 16.2
Formerly married, not cohabiting . . . . 3,144 100.0 58.2 3.8 18.9 6.7 4.2 3.5 4.7
Never married, not co h a b itin g ........... . 8,978 100.0 11.5 0.8 46.0 23.2 5.7 2.7 10.1
2002:
Currently m a rried ................................. . 20,655 100.0 29.8 15.4 23.6 16.4 3.1 2.6 9.1
Currently cohabiting.............................. . 4,039 100.0 25.4 3.1 33.2 18.1 9.3 1.7 9.3
Formerly married, not cohabiting . . . . 3,924 100.0 54.9 3.3 19.1 12.5 2.7 2.9 4.6
Never married, not co h a b itin g ........... 9,491 100.0 10.0 0.9 49.4 23.4 9.6 0.5 6.2
Parity
2006-2008:
0 b ir th s .................................................. . 11,919 100.0 2.0 2.0 55.3 24.6 3.3 0.3 12.6
1 b ir th .................................................... . 6,163 100.0 12.8 9.0 29.8 22.1 4.2 8.4 13.7
2 b ir th s .................................................. . 10,490 100.0 34.9 17.4 14.4 12.0 3.3 10.9 7.2
3 or more b irth s .................................... . 9,643 100.0 58.7 12.1 7.9 6.3 2.3 4.2 8.5
2002:
0 b ir th s .................................................. . 11,786 100.0 2.0 3.2 56.8 24.4 5.7 0.5 7.5
1 b ir th .................................................... . 6,702 100.0 13.0 4.7 33.0 22.4 10.0 2.4 14.6
2 b ir th s .................................................. . 10,415 100.0 38.2 15.5 17.9 14.3 3.8 3.3 7.1
3 or more b irth s .................................... 9,205 100.0 56.4 13.2 9.8 10.6 3.2 2.4 4.5
* F igure does not meet standards of reliability or precision.
-  Q uantity zero.
1Includes women of other or multiple race and origin groups and women who do not know  whether they intend to  have more children, not shown separately 
NOTE: Standard errors are in A ppend ix Table I.
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Table 11. Number of women aged 15-44 years who are currently using a method of contraception and percent distribution by method,











No high school diploma or G E D .......................... . . 4,166 100.0 55.4 3.1 10.4 9.5 6.2 4.0 11.3
High school diploma or G E D .............................. . . . 8,669 100.0 42.5 13.0 18.4 10.1 2.9 4.9 8.3
Some college, no bachelor's degree ................ . . . 9,324 100.0 27.4 11.1 23.4 15.7 2.7 7.2 12.5
Bachelor's degree or h igher................................. . . . 10,962 100.0 16.3 13.6 34.7 20.2 0.7 5.7 8.6
2002:
No high school diploma or G E D ......................... . . 3,887 100.0 55.3 2.8 10.6 13.2 7.4 2.5 8.3
High school diploma or G E D .............................. . . . 9,996 100.0 41.5 10.8 19.0 13.1 4.9 2.5 8.3
Some college, no bachelor's degree ................ . . . 9,954 100.0 28.7 12.1 27.6 17.9 3.2 2.3 8.1
Bachelor's degree or h igher................................. 8,741 100.0 12.8 12.8 41.8 20.8 1.9 2.0 8.0
Poverty level income2
2006-2008:
0% -149% ............................................................... . . 9,941 100.0 42.7 4.0 18.6 14.9 5.2 5.5 9.3
0 % -9 9 % .............................................................. . . 6,191 100.0 44.9 1.9 20.1 12.0 6.9 4.8 9.5
15 0% -299% .......................................................... . . . 10,800 100.0 31.6 11.7 21.0 15.9 2.3 5.5 12.0
300% or m o re ....................................................... . . . 14,533 100.0 18.5 14.6 34.4 15.7 1.3 5.9 9.6
2002:
0% -149% ............................................................... . . 9,525 100.0 40.5 4.7 20.8 15.0 6.9 3.4 8.7
0 % -9 9 % .............................................................. . . 6,088 100.0 42.1 5.0 20.4 13.7 7.1 4.1 7.7
15 0% -299% .......................................................... . . . 9,998 100.0 33.4 9.4 25.3 16.1 5.0 2.1 8.7
300% or m o re ....................................................... 15,490 100.0 19.9 13.7 35.6 19.1 2.8 1.5 7.3
Intent to have more children
2006-2008:
Intends m o re .......................................................... . . 14,260 100.0 - 0.3 47.6 26.7 4.4 5.7 15.3
Intends no m o re .................................................... . . . 23,382 100.0 44.2 16.0 15.8 9.6 2.5 5.0 6.9
2002:
Intends m o re .......................................................... . . 14,213 100.0 * 0.2 51.4 26.8 8.3 2.0 11.3
Intends no m o re .................................................... 23,361 100.0 44.0 14.9 17.7 12.3 3.5 2.1 5.5
Race and Hispanic origin
2006-2008:
H ispanic.................................................................. . . 6,072 100.0 33.5 5.8 19.5 16.1 4.4 8.3 12.4
Non-Hispanic:
White, single race ............................................ . . 24,353 100.0 23.0 12.9 32.7 14.7 2.1 5.1 9.6
Black, single race ............................................ . . . 4,605 100.0 39.9 1.9 20.9 16.2 7.5 5.2 8.4
All other single race and multiple ra c e ............ . . 3,184 100.0 27.3 6.6 18.4 27.3 3.0 3.7 13.8
2002:
Hispanic.................................................................. . . 5,370 100.0 33.8 4.4 22.0 18.5 7.3 5.3 8.8
Non-Hispanic:
White, single race ............................................ . . 25,513 100.0 23.9 11.7 34.4 16.6 4.2 1.5 7.8
Black, single race ............................................ . . . 4,754 100.0 39.2 2.3 22.7 19.8 9.4 1.5 5.2
All other single race and multiple ra c e ........... 2,472 100.0 20.9 7.0 25.4 27.7 5.2 1.5 12.4
-  Q uantity zero.
* F igure does not meet standards of re liability or precision. 
1Limited to  women 2 2 -4 4  years of age at tim e of interview, 
2Limited to  women 2 0 -4 4  years of age at tim e of interview, 
NOTE: Standard errors are in Appendix Table II,
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Table 12. Number of women aged 15-44 years, percentage currently using contraception, and percentage who used each of the specified
contraceptive methods in the month of interview, according to current marital status: United States, 2006-2008
Contraceptive status and method
Marital and cohabitation status






















Number of women in thousands.................................... 61,864 27,006 34,858
Percentage that used the method
Currently using contraception......................................... , , 61,8 61,8 78.6 78.6 48,7 48,7
Female sterilization....................................................... , , 16,7 16,7 23.6 23.6 11,4 11,4
Male steriliza tion.......................................................... , , 6,1 6,7 12.7 13.7 1,0 1,3
P ill................................................................................... , , 17,3 17,9 16.3 17.4 18,1 18,3
Norplant™, Lunelle™, or p a tc h ................................. , , 0,7 0,7 0.7 0.7 0,7 0,7
3-month injectable (Depo-Provera™)......................... , , 2,0 2,0 1.4 1.4 2,4 2,5
Contraceptive r in g ....................................................... , , 1,5 1,5 1.0 1.1 1,8 1,8
Intrauterine device ( IU D ) ............................................ , , 3,4 3,4 5.3 5.3 1,9 2,0
C o n d o m ........................................................................ , , 10,0 13,9 11.7 13.8 8,6 14,0
Periodic abstinence—calendar rhythm ...................... , , 0,5 1,1 1.0 1.8 0,2 0,6
Periodic abstinence—natural family planning........... , , 0,1 0,4 0.2 0.7 * *
W ithdrawal..................................................................... , , 3,2 6,2 4.5 7.3 2,2 5,4
Other methods2 ............................................................. 0,3 0,5 0.3 0.6 0,2 0,3
* F igure does not meet standards of re liability or precision,
''Percentages will not add to  the  tota l who were using contraception because more than one method could have been used in the  month of interview. Respondents could list as many as fou r current 
contraceptive  methods,
2Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervical cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
diaphragm ), and other methods,
NOTE: Standard errors are in Appendix Table III,
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Table 13. Number of women aged 15-44 years, percentage currently using contraception, and percentage who used the specified
contraceptive method in the month of interview, according to Hispanic origin and race: United States, 2006-2008
Non-Hispanic
Hispanic White, single race Black, single race Other single race or multiple race





























Number of women in thousands................................. 10,377 37,660 8,452
Percentage that used the method
5,375
Currently using con traception.................................... . 58.5 58.5 64.7 64.7 54.5 24.5 59,2 59,2
Female steriliza tion.................................................. . 19.6 19.6 14.9 14.9 21.8 21.8 16,1 16,1
Male sterilization....................................................... . 3.4 3.6 8.3 9.1 1.1 1.3 3,9 4,6
P i l l ............................................................................. . 11.4 11.5 21.2 22.0 11.4 11.9 10,9 11,0
Norplant™, Lunelle™, or pa tch .............................. . 1.5 1.5 0.5 0.5 0.6 0.6 1,0 1,0
3-month injectable (Depo-Provera™ )................... . 2.6 2.6 1.4 1.4 4.1 4.1 1,8 1,8
Contraceptive r in g .................................................... . 1.2 1.2 1.6 1.7 1.7 1.7 0,8 0,8
Intrauterine device (IU D )......................................... . 4.8 4.8 3.3 3.3 2.8 3.0 2,2 2,2
C ondom ..................................................................... . 9.4 11.3 9.5 13.6 8.8 14.8 16,2 19,6
Periodic abstinence—calendar rhythm................... . 0.6 1.5 0.5 1.0 * 0.5 1,0 2,1
Periodic abstinence—natural family planning , , , . * * * 0.4 * * * *
W ithd raw a l................................................................ . 3.0 5.7 3.3 6.7 2.1 3.4 5,1 8,5
Other methods2 ....................................................... 0.5 0.6 0.3 0.5 * * * 0,5
* F igure does not meet standards of re liability or precision,
1Percentages will not add to  the  tota l who were using contraception because more than one method could have been used in the  month of interview. Respondents could list as many as fou r current 
contraceptive  methods,
2Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervical cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
d iaphragm ), and other methods,
NOTE: Standard errors are in Appendix Table IV.
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Table 14. Number of women aged 15-44 years, percentage currently using contraception, and percentage who used the specified
contraceptive method in month of interview, according to age at interview: United States, 2006-2008























Number of women in thousands....................................... 20,570 19,837 21,457
Percentage that used the method
Currently using contraception............................................ . 41.3 41.3 67.2 67.2 76.5 76.5
Female sterilization.......................................................... . 0.7 0.7 14.9 14.9 33.8 33.8
Male steriliza tion............................................................. . 0.2 0.2 3.9 4.4 13.9 15.2
P ill...................................................................................... . 20.7 20.7 20.1 20.9 11.5 12.5
Norplant™, Lunelle™, or p a tc h .................................... . 0.6 0.6 1.1 1.1 0.4 0.4
3-month injectable (Depo-Provera™)............................ . 2.7 2.7 2.5 2.5 0.8 0.9
Contraceptive r in g .......................................................... . 2.2 2.2 1.9 1.9 0.5 0.5
Intrauterine device ( IU D ) ............................................... . 2.1 2.1 4.3 4.4 3.8 3.8
C o n d o m ........................................................................... . 9.9 15.4 12.6 17.7 7.6 8.9
Periodic abstinence—calendar rhythm ......................... . 0.2 0.3 0.7 1.5 0.7 1.5
Periodic abstinence—natural family planning.............. . - * 0.3 0.4 0.1 0.6
W ithdrawal........................................................................ . 1.9 5.3 4.4 8.4 3.3 5.0
Other methods2 ................................................................ 0.2 0.2 0.5 0.9 0.2 0.3
-  Q uantity zero,
* F igure does not meet standards of re liability or precision,
1Percentages will not add to  the  tota l who were using contraception because more than one method could have been used in the  month of interview. Respondents could list as many as fou r current 
contraceptive  methods,
2Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervical cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
d iaphragm ), and other methods,
NOTE: Standard errors are in Appendix Table V.
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Table 15. Number of women aged 15-44 years who ever used a selected method of contraception, percentage who discontinued that 


















Total who ever used the m ethod......................... 45,082 49,521 12,050 5,415 6,382 29,510 5,802
Percent (standard error)
Percentage who discontinued method................ 30.1 (1.08) 10.8 (1.02) 43.4 (2.14) 50.4 (2.78) 35.2 (2.80) 28.5 (1.34) 29.8 (2.43)
Number in thousands
Total who stopped using the method due to
dissatisfaction....................................................... 13,589 5,340 5,234 2,728 2,247 8,411 1,729
Reason for discontinuation Percent (standard error)
Too expens ive ....................................................... . 2.9 (0.57) 2.9 (1.42) 2.0 (1.48) 3.4 (1.87) 3.4 (1.63) 3.3 (0.71) 1.4 (0.92)
Insurance did not cover i t .................................... . 2.1 (0.57) * * * * 2.6 (0.65) *
Too diffcult to u s e .................................................. . 9.9(1.47) 7.7 (1.86) * 8.7 (2.14) 10.2 (3.04) 9.3 (2.02) 13.6 (2.53)
Too messy............................................................... . 0.3 (0.12) 8.9 (1.67) 0.4 (0.19) 5.9 (1.91) * * *
Your partner did not l ike i t .................................... . 1.4(0.43) 41.4 (4.63) * * * 1.3 (0.45) *
You had side effects............................................... . 63.7(1.83) 12.0 (2.52) 75.5 (3.15) 42.2 (5.09) 65.8 (4.30) 63.1 (2.75) 59.1 (3.23)
You were worried you might have side
e ffe c ts .................................................................. . 12.5(1.46) * 8.3 (1.78) 8.2 (2.40) 16.6 (4.47) 12.7 (1.78) 8.4 (2.50)
You worried the method would not w o r k ........... . 2.5 (0.58) 23.0 (4.03) 1.0 (0.36) 7.6 (2.98) 2.6 (0.92) 2.1 (0.80) 5.0 (1.91)
The method failed, you became pregnant . . . . . 10.1 (1.32) 5.2 (1.75) 2.4 (0.50) 11.2 (3.40) 10.9 (3.21) 10.4 (1.89) 11.2 (2.22)
The method did not protect against disease . . . . 1.8 (0.74) - 0.5 (0.31) * * 2.2 (1.17) 1.7 (0.96)
Doctor told you not to use the method again. . . . 5.7(1.12) 1.7 (0.92) 5.1 (1.23) 5.0 (1.65) 4.3 (1.13) 6.6 (1.65) 5.6 ( 1.53)
Decreased your sexual p leasure......................... . 5.4 (0.86) 40.0 (4.71) 4.2 (1.15) * 4.4 (1.42) 6.3 (1.31) 4.2 (2.90)
Too difficult to o b ta in ............................................ . 2.1 (0.56) - * * * 2.6 (0.87) 2.5 (1.08)
Did not like changes to menstrual cycle.............. . 10.6(1.37) * 25.5 (2.90) 8.4 (2.81) 9.2 (2.66) 11.0 (1.77) 10.6 (2.38)
O ther........................................................................ 9.8 (1.08) 10.8 (2.89) 5.7 (1.04) 15.0 (2.85) 7.6 (2.37) 10.9 (1.63) 9.5 ( 1.56)
* F igure does not meet standards of re liability or precision. 
-  Q uantity zero.
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Appendix I. Technical 
Notes
Sample Design and 
Fieldwork Procedures
The 2006-2008 National Survey of 
Family Growth, or NSFG, was based on 
13,495 face-to-face interviews— 7,356 
with women and 6,139 with men— aged 
15-44 years in the household population 
of the United States. The interviews 
were administered in person by trained 
female interviewers in the selected 
persons’ homes. The 2006-2008 sample 
is a nationally representative multistage 
area probability sample drawn from 85 
areas across the country. The sample is 
designed to produce national, not state, 
estimates.
Persons were selected for the NSFG 
in five major steps:
•  Large areas (counties and cities) 
were chosen first.
•  Within each large area or ‘‘Primary 
Sampling Unit,’’ groups of adjacent 
blocks, called segments, were 
chosen at random.
•  Within segments, addresses were 
listed and some addresses were 
selected at random.
•  The selected addresses were visited 
in person, and a short ‘‘screener’’ 
interview was conducted to see if 
anyone 15-44 years of age lived 
there.
•  If so, one person was chosen at 
random for the interview and was 
offered a chance to participate.
To protect the respondent’s privacy, 
only one person was interviewed in each 
selected household. In 2006-2008 as 
well as in 2002, teenagers and black and 
Hispanic adults were sampled at higher 
rates than others.
The NSFG questionnaires and 
materials were reviewed and approved 
by the NCHS Research Ethics Review 
Board (formerly known as the 
Institutional Review Board or IRB), and 
by the IRB at the University of 
Michigan. The female questionnaire 
lasted an average of about 70 minutes.
All respondents were given written and 
oral information about the survey and 
were informed that participation was 
voluntary. Adult respondents 18-44 
years of age were asked to sign a 
consent form but were not required to 
do so. For minors 15-17 years of age, 
signed consent was required first from a 
parent or guardian, and then signed 
assent was required from the minor. 
Consent forms were signed electro­
nically on the interviewer’s computer. 
The overall response rate for the survey 
was about 75%— about 76% for women 
and 73% for men.
About 100 female interviewers were 
hired and trained by the survey 
contractor, the University of Michigan’s 
Institute for Social Research, under the 
supervision of NCHS. Interviewing 
occurred from about July 1, 2006, 
through December 2008. All of the data 
in this report were collected by 
computer-assisted personal interviewing 
(CAPI). The questionnaires were 
programmed into laptop computers and 
administered by an interviewer, usually 
in the respondent’s home. Respondents 
in the 2006-2008 survey were offered 
$40 as a ‘‘token of appreciation’’ for 
their participation. More detailed 
information about the methods and 
procedures of the study has been 
described in a report on the planning 
and development of the continuous 
NSFG (1) and another report on the 
continuous NSFG’s sample design, 
weighting, imputation, and variance 
estimation (20).
All weighted numbers in this report 
were individually rounded to the nearest 
thousand. In addition, all percentages 
were rounded to the nearest tenth (e.g., 
23.1%). Aggregate numbers and 
percentages may not always add to the 
total because of this rounding.
Sampling Errors in the 
2006-2008 National Survey 
of Family Growth
Looking at Tables 1, 4 , and 9, 
which contain trend data from several 
NSFG surveys, readers may notice that 
the standard errors (and therefore the 
confidence intervals) of comparable
statistics are somewhat larger in 
2006-2008 than they were in the 1995 
and 2002 NSFG surveys. This is a 
predictable result of the design of the 
2006-2008 NSFG, which has been 
interviewing in a smaller number of 
areas (85 areas, or ‘‘Primary Sampling 
Units,’’ in 2006-2008 compared with 
120 areas in 2002 and 198 areas in 
1995). This use of a smaller number of 
areas at a time reduces the cost of the 
NSFG and increases quality control, but 
it increases sampling errors.
For most statistics in this report, 
these increased sampling errors do not 
pose a problem, because most groups 
shown in this report are based on large 
sample sizes. If an analyst wishes to 
examine a very small segment of the 
population, such as Hispanic female 
contraceptive users 20-24 years of age, 
it may be worthwhile to use a somewhat 
larger group, such as Hispanic female 
contraceptive users 20-29 years of age, 
to compensate for the larger standard 
errors.
The next NSFG data file is 
expected to be released in 2011. That 
file will have the 13,495 interviews 
completed in 2006-2008, plus another 
9,000 or more conducted from January 
2009 through June 2010, for a total of 
approximately 22,500 interviews drawn 
from 110 areas. Sampling errors using 
those data are expected to be 
significantly smaller because of the 
larger sample size, and the larger 
number of areas from which the 
interviews are drawn. That sample will 
allow analyses of small subgroups for 
both men and women.
Standard errors for the statistics are 
shown in most of the tables of this 
report. In Tables 10-14, however 
standard errors were omitted to make 
the tables easier to read. The standard 
errors for the statistics in Tables 10-14 
are shown in Appendix Tables I-V .
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Table I. Number of women aged 15-44 years who are currently using a method of contraception and percent distribution by method,













Percent distribution (standard errors)
All women1
2006-2008 .................................................... . . 38,214 100.0 27.1 (1.46) 9.9 (0.83) 28.0 (1.32) 16.1 (0.94) 3.2 (0.38) 5.5 (0.83) 10.2 (0.70)
2002................................................................ 38,109 100.0 27.0 (0.92) 9.2 (0.61) 30.6 (0.93) 18.0 (0.70) 5.3 (0.45) 2.0 (0.27) 7.9 (0.51)
Age
2006-2008:
15-19 years............................................... . . 2,941 100.0 * - 54.1 (3.63) 22.8 (2.59) 9.4 (1.67) 3.6 (2.02) 10.1 (2.04)
20-24 years............................................... . . 5,548 100.0 2.4 (0.73) 0.7 (0.31) 48.0 (2.87) 24.5 (1.91) 5.1 (1.17) 5.9 (1.20) 13.4 (1.93)
25-29 years............................................... . . 6,583 100.0 15.0 (1.74) 3.3 (0.81) 35.1 (2.53) 20.5 (1.94) 5.2 (1.01) 6.2 (1.18) 14.7 (1.76)
30-34 years............................................... . . 6,737 100.0 29.3 (3.17) 8.3 (1.27) 24.8 (2.39) 17.1 (2.45) 2.2 (0.53) 6.6 (1.69) 11.7 (1.51)
35-39 years............................................... . . 7,859 100.0 37.6 (3.18) 16.5 (2.13) 19.3 (2.33) 11.2 (2.01) 1.0 (0.44) 5.8 (2.09) 8.6 (2.14)
40-44 years............................................... . . 8,547 100.0 50.2 (3.23) 19.6 (2.97) 11.1 (1.94) 8.8 (1.53) 1.1 (0.41) 4.2 (1.13) 5.1 (1.09)
2002:
15-19 years............................................... . . 3,096 100.0 - - 52.8 (3.31) 27.0 (2.89) 13.9 (2.36) * 6.0 (1.24)
20-24 years............................................... . . 5,975 100.0 3.6 (0.71) 0.8 (0.31) 52.3 (2.58) 23.1 (1.99) 10.1 (1.34) 1.8 (0.32) 8.3 (1.28)
25-29 years............................................... . . 6,291 100.0 15.1 (1.45) 4.2 (0.71) 37.6 (2.12) 20.5 (1.93) 6.5 (0.90) 3.7 (0.77) 12.4 (1.52)
30-34 years............................................... . . 7,105 100.0 27.5 (1.75) 9.2 (1.17) 31.5 (1.95) 17.1 (1.30) 4.2 (0.87) 3.1 (0.74) 7.5 (0.98)
35-39 years............................................... . . 7,688 100.0 41.2 (2.19) 14.2 (1.66) 18.6 (1.66) 15.7 (1.49) 2.1 (0.66) 1.5 (0.46) 6.8 (1.18)
40-44 years............................................... 7,955 100.0 50.3 (2.57) 18.4 (2.00) 10.9 (1.13) 11.5 (1.63) 1.6 (0.72) 1.1 (0.57) 6.2 (1.27)
Marital or cohabiting status 
2006-2008:
Currently married....................................... . . 21,238 100.0 30.0 (2.19) 16.2 (1.41) 20.7 (1.90) 14.9 (1.26) 1.7 (0.41) 6.7 (1.11) 9.8 (1.05)
Currently cohabiting................................. . . 4,855 100.0 22.9 (2.97) 3.2 (0.88) 32.5 (3.16) 14.3 (1.92) 4.4 (0.90) 6.6 (2.09) 16.2 (2.28)
Formerly married, not cohabiting........... . . 3,144 100.0 58.2 (3.66) 3.8 (1.19) 18.9 (3.00) 6.7 (1.35) 4.2 (1.05) 3.5 (1.47) 4.7 (0.99)
Never married, not cohabiting................ . . 8,978 100.0 11.5 (1.54) 0.8 (0.29) 46.0 (2.16) 23.2 (1.86) 5.7 (0.68) 2.7 (0.83) 10.1 (1.29)
2002:
Currently married....................................... . . 20,655 100.0 29.8 (1.50) 15.4 (1.07) 23.6 (1.13) 16.4 (0.97) 3.1 (0.43) 2.6 (0.40) 9.1 (0.77)
Currently cohabiting................................. . . 4,039 100.0 25.4 (2.40) 3.1 (0.78) 33.2 (2.33) 18.1 (1.97) 9.3 (1.57) 1.7 (0.50) 9.3 (1.45)
Formerly married, not cohabiting........... . . 3,924 100.0 54.9 (2.32) 3.3 (1.15) 19.1 (1.97) 12.5 (1.77) 2.7 (0.64) 2.9 (0.90) 4.6 (0.94)
Never married, not cohabiting................ 9,491 100.0 10.0 (1.29) 0.9 (0.22) 49.4 (2.33) 23.4 (1.40) 9.6 (1.09) 0.5 (0.23) 6.2 (0.89)
Parity
2006-2008:
0 b irths....................................................... . . 11,919 100.0 2.0 (0.41) 2.0 (0.40) 55.3 (2.22) 24.6 (1.94) 3.3 (0.60) 0.3 (0.10) 12.6 (1.39)
1 birth.......................................................... . . 6,163 100.0 12.8 (1.89) 9.0 (2.03) 29.8 (2.60) 22.1 (2.82) 4.2 (0.89) 8.4 (1.81) 13.7 (1.49)
2 b irths....................................................... . . 10,490 100.0 34.9 (2.31) 17.4 (2.08) 14.4 (2.04) 12.0 (1.30) 3.3 (0.69) 10.9 (2.33) 7.2 (0.82)
3 or more b ir th s ....................................... . . 9,643 100.0 58.7 (3.10) 12.1 (2.09) 7.9 (1.53) 6.3 (1.18) 2.3 (0.54) 4.2 (0.66) 8.5 (1.83)
2002:
0 b irths....................................................... . . 11,786 100.0 2.0 (0.42) 3.2 (0.53) 56.8 (1.85) 24.4 (1.43) 5.7 (0.72) 0.5 (0.22) 7.5 (0.90)
1 birth.......................................................... . . 6,702 100.0 13.0 (1.35) 4.7 (0.91) 33.0 (1.91) 22.4 (1.54) 10.0 (1.28) 2.4 (0.62) 14.6 (1.67)
2 b irths....................................................... . . 10,415 100.0 38.2 (1.84) 1.5 (1.69) 17.9 (1.43) 14.3 (1.32) 3.8 (0.54) 3.3 (0.57) 7.1 (0.85)
3 or more b ir th s ....................................... 9,205 100.0 56.4 (2.03) 13.2 (1.37) 9.8 (1.05) 10.6 (1.39) 3.2 (0.58) 2.4 (0.51) 4.5 (0.93)
* F igure does not meet standards of re liability or precision.
-  Q uantity zero.
1Includes women of o ther or multiple race and origin groups and wom en who do not know whether they intend to  have more children, not shown separately 
NOTE: Standard errors are fo r percentages in Table 10.
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Table II. Number of women aged 15-44 years who are currently using a method of contraception and percent distribution by method,







method Female Male Pill Condom IUD
Percent distribution (standard errors)
Education1
2006-2008:
No high school diploma or GED................... 4,166 100.0 55.4 (3.72) 3.1 (1.13) 10.4 (1.75) 9.5 (1.64) 6.2 (1.53) 4.0 (1.46) 11.3 (2.14)
High school diploma or GED......................... 8,669 100.0 42.5 (2.58) 13.0 (1.77) 18.4 (2.29) 10.1 (1.35) 2.9 (0.62) 4.9 (0.86) 8.3 (1.58)
Some college, no bachelor's degree........... 9,324 100.0 27.4 (2.20) 11.1 (2.00) 23.4 (1.99) 15.7 (1.53) 2.7 (0.79) 7.2 (1.38) 12.5 (1.59)
Bachelor's degree or h igh e r......................... 10,962 100.0 16.3 (3.26) 13.6 (1.70) 34.7 (2.23) 20.2 (2.25) 0.7 (0.25) 5.7 (1.62) 8.6 (1.15)
2002:
No high school diploma or GED................... 3,887 100.0 55.3 (3.24) 2.8 (1.10) 10.6 (1.44) 13.2 (1.67) 7.4 (1.59) 2.5 (0.64) 8.3 (1.59)
High school diploma or GED......................... 9,996 100.0 41.5 (1.58) 10.8 (0.96) 19.0 (1.34) 13.1 (1.06) 4.9 (0.78) 2.5 (0.59) 8.3 (1.15)
Some college, no bachelor's degree........... 9,954 100.0 28.7 (1.71) 12.1 (1.59) 27.6 (1.76) 17.9 (1.38) 3.2 (0.50) 2.3 (0.54) 8.1 (1.16)
Bachelor's degree or higher ......................... 8,741 100.0 12.8 (1.43) 12.8 (1.47) 41.8 (1.88) 20.8 (1.81) 1.9 (0.41) 2.0 (0.46) 8.0 (1.01)
Poverty level income2
2006-2008:
0 % -14 9% ....................................................... 9,941 100.0 42.7 (2.47) 4.0 (0.79) 18.6 (1.55) 14.9 (1.65) 5.2 (0.81) 5.5 (1.06) 9.3 (1.34)
0%-99%....................................................... 6,191 100.0 44.9 (3.50) 1.9 (0.83) 20.1 (2.63) 12.0 (1.41) 6.9 (1.14) 4.8 (1.12) 9.5 (2.06)
150%-299%..................................................... 10,800 100.0 31.6 (2.66) 11.7 (1.79) 21.0 (1.91) 15.9 (1.43) 2.3 (0.56) 5.5 (0.74) 12.0 (1.55)
300% or more.................................................. 14,533 100.0 18.5 (2.02) 14.6 (1.53) 34.4 (1.92) 15.7 (1.53) 1.3 (0.37) 5.9 (1.55) 9.6 (1.15)
2002:
0%-149% ........................................................ 9,525 100.0 40.5 (2.18) 4.7 (1.12) 20.8 (1.60) 15.0 (1.16) 6.9 (0.97) 3.4 (0.53) 8.7 (1.16)
0%-99%........................................................ 6,088 100.0 42.1 (2.65) 5.0 (1.62) 20.4 (1.92) 13.7 (1.45) 7.1 (1.22) 4.1 (0.73) 7.7 (1.30)
150%-299%.................................................... 9,998 100.0 33.4 (1.91) 9.4 (1.23) 25.3 (1.54) 16.1 (1.31) 5.0 (0.74) 2.1 (0.66) 8.7 (0.97)
300% or more.................................................. 15,490 100.0 19.9 (1.23) 13.7 (0.97) 35.6 (1.34) 19.1 (1.29) 2.8 (0.49) 1.5 (0.30) 7.3 (0.83)
Intent to have more children 
2006-2008:
Intends m o re .................................................. 14,260 100.0 - 0.3 (0.14) 47.6 (1.98) 26.7 (1.71) 4.4 (0.66) 5.7 (0.97) 15.3 (1.40)
Intends no m o re ............................................ 23,382 100.0 44.2 (2.14) 16.0 (1.34) 15.8 (1.47) 9.6 (0.97) 2.5 (0.36) 5.0 (0.90) 6.9 (0.90)
2002:
Intends more .................................................. 14,213 100.0 * 0.2 (0.13) 51.4 (1.56) 26.8 (1.40) 8.3 (0.83) 2.0 (0.34) 11.3 (0.89)
Intends no more ............................................. 23,361 100.0 44.0 (1.26) 14.9 (0.95) 17.7 (0.94) 12.3 (0.76) 3.5 (0.46) 2.1 (0.39) 5.5 (0.58)
Race and Hispanic origin 
2006-2008:
Hispanic ........................................................... 6,072 100.0 33.5 (3.47) 5.8 (1.55) 19.5 (2.45) 16.1 (1.53) 4.4 (0.87) 8.3 (1.25) 12.4 (1.54)
Non-Hispanic:
White, single race ....................................... 24,353 100.0 23.0 (1.76) 12.9 (1.01) 32.7 (1.68) 14.7 (1.15) 2.1 (0.32) 5.1 (1.04) 9.6 (0.91)
Black, single race ....................................... 4,605 100.0 39.9 (2.71) 1.9 (0.76) 20.9 (1.65) 16.2 (2.48) 7.5 (1.56) 5.2 (1.75) 8.4 (1.34)
All other single race and multiple race ......... 3,184 100.0 27.3 (5.89) 6.6 (2.89) 18.4 (3.25) 27.3 (5.06) 3.0 (0.93) 3.7 (0.82) 13.8 (2.33)
2002:
Hispanic ........................................................... 5,370 100.0 33.8 (2.48) 4.4 (0.69) 22.0 (1.40) 18.5 (1.69) 7.3 (1.35) 5.3 (0.89) 8.8 (0.96)
Non-Hispanic:
White, single race ....................................... 25,513 100.0 23.9 (1.19) 11.7 (0.83) 34.4 (1.17) 16.6 (0.92) 4.2 (0.54) 1.5 (0.29) 7.8 (0.70)
Black, single race ....................................... 4,754 100.0 39.2 (2.05) 2.3 (0.87) 22.7 (1.92) 19.8 (1.43) 9.4 (1.20) 1.5 (0.53) 5.2 (0.77)
All other single race and multiple race . . 2,472 100.0 20.9 (2.88) 7.0 (2.82) 25.4 (2.62) 27.7 (3.21) 5.2 (1.34) 1.5 (0.70) 12.4 (3.01)
-  Q uantity zero.
* F igure does not meet standards of re liability or precision. 
1Limited to  women 2 2 -4 4  years of age at tim e of interview. 
2Limited to  women 2 0 -4 4  years of age at tim e of interview.
Page 36 □  Series 23, No. 29
Table III. Number of women aged 15-44 years, percentage currently using contraception, and percentage who used each of the specified
contraceptive methods in the month of interview, according to current marital status: United States, 2006-2008
Contraceptive status and method
All women
Marital and cohabitation status 






















Number of women in thousands.................................... 61,864 27,006 34,858
Percentage (standard error) that used the method
Currently using contraception......................................... . . 61.8(1.22) 61.8 (1.21) 78.6 (1.25) 78.6 (1.25) 48.7 ( 1.91) 48.7 (1.91)
Female sterilization....................................................... . . 16.7(0.96) 16.7 (0.96) 23.6 (1.82) 23.6 (1.82) 11.4 (0.92) 11.4 (0.92)
Male steriliza tion.......................................................... . . 6.1 (0.53) 6.7 (0.58) 12.7 (1.14) 13.7 (1.23) 1.0 (0.19) 1.3 (0.27)
P ill................................................................................... . . 17.3(0.83) 17.9 (0.86) 16.3 (1.46) 17.4 (1.50) 18.1 (1.16) 18.3 (1.15)
Norplant™, Lunelle™, or p a tc h ................................. . . 0.7(0.12) 0.7 (0.12) 0.7 (0.20) 0.7 (0.20) 0.7 (0.14) 0.7 (0.14)
3-month injectable (Depo-Provera™)......................... . . 2.0(0.24) 2.0 (0.24) 1.4 (0.32) 1.4 (0.32) 2.4 (0.27) 2.5 (0.28)
Contraceptive r in g ....................................................... . . 1.5 (0.22) 1.5 (0.22) 1.0 (0.25) 1.1 (0.26) 1.8 (0.36) 1.8 (0.36)
Intrauterine device ( IU D ) ............................................ . . 3.4(0.52) 3.4 (0.52) 5.3 (0.85) 5.3 (0.85) 1.9 (0.46) 2.0 (0.46)
C o n d o m ........................................................................ . . 10.0(0.63) 13.9 (0.69) 11.7 (1.03) 13.8 (1.13) 8.6 (0.62) 14.0 (0.84)
Periodic abstinence—calendar rhythm ...................... . . 0.5 (0.10) 1.1 (0.16) 1.0 (0.23) 1.8 (0.30) 0.2 (0.07) 0.6 (0.16)
Periodic abstinence—natural family planning........... . . 0.1 (0.06) 0.4 (0.13) 0.2 (0.07) 0.7 (0.28) * *
Withdrawal..................................................................... . . 3.2(0.33) 6.2 (0.42) 4.5 (0.69) 7.3 (0.79) 2.2 (0.31) 5.4 (0.53)
Other methods2 ........................................................... 0.3 (0.09) 0.5 (0.11) 0.3 (0.10) 0.6 (0.15) 0.2 (0.11) 0.3 (0.11)
* F igure does not meet standards of re liability or precision.
1P ercentages w ill not add to  the  to ta l who were using contraception because more than one method could have been used in the  m onth of interview. R espondents could list as many as fou r current 
contraceptive  methods.
2Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervica l cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
d iaphragm ), and other methods.
Table IV. Number of women aged 15-44 years, percentage currently using contraception, and percentage who used the specified 
contraceptive method in the month of interview, according to Hispanic origin and race: United States, 2006-2008
Race and Hispanic origin
Non-Hispanic
Hispanic White, single race Black, single race Other single race or multiple race





























Number of women in thousands................... 10,377 37,660 8,452 5,375
Currently using contraception......................... . 58.5(1.90) 58.5 (1.90)
Percentage (standard error) that used the method 
64.7 (1.59) 64.7 (1.59) 54.5 (2.54) 24.5 (2.54) 59.2 (3.00) 59.2 (3.00)
Female ste riliza tion .................................... . 19.6(2.09) 19.6 (2.09) 14.9 (1.22) 14.9 (1.22) 21.8 (1.89) 21.8 (1.89) 16.1 (3.70) 16.1 (3.70)
Male sterilization......................................... . 3.4(0.91) 3.6 (0.92) 8.3 (0.71) 9.1 (0.76) 1.1 (0.42) 1.3 (0.50) 3.9 (1.73) 4.6 (1.82)
P ill.................................................................. . 11.4(1.53) 11.5 ( 1.53) 21.2 (1.11) 22.0 (1.12) 11.4 (1.13) 11.9 (1.39) 10.9 (1.88) 11.0 (1.88)
Norplant™, Lunelle™, or p a tch ................ . 1.5 (0.43) 1.5 (0.43) 0.5 (0.09) 0.5 (0.09) 0.6 (0.16) 0.6 (0.16) 1.0 (0.55) 1.0 (0.55)
3-month injectable (Depo-Provera™) . . . . 2.6 (0.52) 2.6 (0.53) 1.4 (0.20) 1.4 (0.21) 4.1 (0.84) 4.1 (0.84) 1.8 (0.52) 1.8 (0.53)
Contraceptive r in g ....................................... . 1.2 (0.42) 1.2 (0.42) 1.6 (0.33) 1.7 (0.33) 1.7 (0.69) 1.7 (0.69) 0.8 (0.31) 0.8 (0.31)
Intrauterine device ( IU D )........................... . 4.8 (0.77) 4.8 (0.77) 3.3 (0.67) 3.3 (0.67) 2.8 (0.95) 3.0 (0.96) 2.2 (0.46) 2.2 (0.46)
C ond om ....................................................... . 9.4 (0.98) 11.3 ( 1.08) 9.5 (0.78) 13.6 (0.88) 8.8 (1.30) 14.8 (1.55) 16.2 (3.16) 19.6 (3.27)
Periodic abstinence—calendar rhythm . . . . 0.6 (0.33) 1.5 (0.43) 0.5 (0.13) 1.0 (0.20) * 0.5 (0.20) 1.0 (0.52) 2.1 (0.72)
Periodic abstinence—natural family 
p lan n ing ....................................................... * * * 0.4 (0.20) * * * *
Withdrawal.................................................... . 3.0 (0.47) 5.7 (0.75) 3.3 (0.49) 6.7 (0.63) 2.1 (0.47) 3.4 (0.61) 5.1 (1.23) 8.5 (1.66)
Other methods2 .......................................... 0.5 (0.35) 0.6 (0.35) 0.3 (0.07) 0.5 (0.12) * * * 0.5 (0.26)
* F igure does not meet standards of re liability or precision.
''Percentages will not add to  the  tota l who were using contraception because more than one method could have been used in the  month of interview. Respondents could list as many as fou r current 
contraceptive  methods.
2Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervical cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
d iaphragm ), and other methods.
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Table V. Number of women aged 15-44 years, percentage currently using contraception, and percentage who used the specified
contraceptive method in month of interview, according to age at interview: United States, 2006-2008
























Number of women in thousands 20,570 19,837 21,457
Percentage (standard error) that used the method
Currently using contraception......................................... . . 41.3(2.19) 41.3 (2.19) 67.2 (1.46) 67.2 (1.46) 76.5 (1.36) 76.5 (1.36)
Female sterilization....................................................... . . 0.7(0.20) 0.7 (0.20) 14.9 (1.41) 14.9 (1.41) 33.8 (1.94) 33.8 (1.94)
Male steriliza tion.......................................................... . . 0.2(0.08) 0.2 (0.08) 3.9 (0.56) 4.4 (0.59) 13.9 (1.40) 15.2 (1.43)
P ill................................................................................... . . 20.7 (1.43) 20.7 (1.42) 20.1 (1.21) 20.9 (1.18) 11.5 (1.30) 12.5 (1.46)
Norplant™, Lunelle™, or p a tc h ................................. . . 0.6 (0.15) 0.6 (0.15) 1.1 (0.29) 1.1 (0.29) 0.4 (0.19) 0.4 (0.19)
3-month injectable (Depo-Provera™)......................... . . 2.7(0.40) 2.7 (0.40) 2.5 (0.40) 2.5 (0.41) 0.8 (0.25) 0.9 (0.25)
Contraceptive r in g ....................................................... . . 2.2 (0.55) 2.2 (0.55) 1.9 (0.35) 1.9 (0.35) 0.5 (0.18) 0.5 (0.18)
Intrauterine device ( IU D ) ............................................ . . 2.1 (0.58) 2.1 (0.58) 4.3 (0.70) 4.4 (0.70) 3.8 (0.92) 3.8 (0.92)
C o n d o m ........................................................................ . . 9.9(0.79) 15.4 (1.02) 12.6 (1.14) 17.7 (1.34) 7.6 (0.97) 8.9 (1.00)
Periodic abstinence—calendar rhythm ...................... . . 0.2(0.07) 0.3 (0.12) 0.7 (0.25) 1.5 (0.34) 0.7 (0.23) 1.5 (0.33)
Periodic abstinence—natural family planning........... . . - * 0.3 (0.16) 0.4 (0.18) 0.1 (0.06) 0.6 (0.34)
Withdrawal..................................................................... . . 1.9(0.37) 5.3 (0.55) 4.4 (0.55) 8.4 (0.91) 3.3 (0.75) 5.0 (0.74)
Other methods2 ........................................................... 0.2 (0.07) 0.2 (0.08) 0.5 (0.20) 0.9 (0.26) 0.2 (0.08) 0.3 (0.10)
-  Q uantity zero.
* F igure does not meet standards of re liability or precision.
P e rce n ta g e s  will not add to  the  tota l who were using contraception because more than one method could have been used in the  month of interview. Respondents could list as many as fou r current 
contraceptive  methods.
2Includes d iaphragm  (with or w ithout je lly  or cream), em ergency contraception, fem ale  condom  or vagina l pouch, foam, cervical cap, Today™  sponge, suppository or insert, je lly  or cream  (w ithout 
diaphragm ), and other methods.




In this report, age (recode = AGER) 
is based on the respondent’s age as of 
the date of the interview. This may 
differ slightly from the respondent’s age 
at the time of the household screening 
interview. Persons were eligible for the 
main NSFG interview if they were 
15-44 years of age when the household 
screening interview was conducted.
Age at first sexual intercourse
In this report, age at first sexual 
intercourse (recode = SEX1AGE) is 
defined as the woman’s age at her first 
intercourse after menarche. It is based 
on the following question:
“Thinking back after your first 
menstrual period, how old were you 
when you had sexual intercourse for  
the first time?”
At risk of unintended 
pregnancy
As discussed in the text surrounding 
Tables 4 -8 , this term (recode = 
CONSTAT1) refers to women who have 
a chance of becoming pregnant at the 
date of interview, but do not want to 
become pregnant now: they are either
(a) using a contraceptive method or
(b) they are not using contraception but 
they have had intercourse in the 3 
months before the interview and are not 
pregnant or trying to become pregnant. 
‘‘Risk of unintended pregnancy’’ is 
measured by combining several 
categories of the CONSTAT1 recode in 
the NSFG data file. Calculating 
contraceptive use or nonuse as a 
proportion of those who are ‘‘at risk of 
unintended pregnancy’’ allows better 
comparisons between groups of women 
by age, race, parity, marital status, and 
other characteristics.
Women who are not at risk of 
unintended pregnancy at the date of 
interview are those who are not using 
contraception because they are:
•  Currently pregnant or postpartum 
(5.4%).
•  Trying to become pregnant (4.1%).
•  Had never had intercourse, or had 
not had intercourse recently 
(19.2%).
•  Were sterile from surgery (most 
commonly, hysterectomy) (0.4%).
•  Were sterile for nonsurgical 
reasons (1.7%).
Those who are ‘‘at risk of unintended 
pregnancy’’ include two groups:
•  The 62% of women who are 
currently using contraception 
(because method use does 
sometimes result in unintended 
pregnancy).
•  The 7.3% of women who have had 
intercourse in the last 3 months but 
were not currently using contraception.
In this report, women using all 
contraceptive methods, including male 
and female sterilization, are classified as 
‘‘at risk and using a method.’’ This was 
done for several reasons: first, because 
female sterilization is the second most 
commonly used method, and male 
sterilization is the fourth most 
commonly used; together they account 
for 37% of all contraceptive users in the 
United States. It is inaccurate to say that 
this large group is not using contra­
ception. Second, sterilization has a low 
but non-zero risk of failure (22), so it can 
be viewed as appropriate to consider these 
women as ‘‘at risk and using a method.’’ 
An alternative definition of ‘‘at risk 
of unintended pregnancy’’ can be 
constructed that classifies those using 
male or female sterilization as ‘‘not at 
risk of unintended pregnancy.’’ If we 
were to define ‘‘at risk of unintended 
pregnancy’’ this way, then the proportion 
using contraception is 84% and the 
proportion ‘‘at risk but not using’’ is 16% 
overall (compared with 11% using the 
definition used in Table 8), 14% for 
Hispanic and non-Hispanic white women, 
and 25% for black women. Given how 
common sterilization is in the United 
States, however, this definition was not 
used in this report.
Contraceptive use at first 
sexual intercourse
This variable (recode = 
SEX1MTHD1-4) is defined only for 
women who have ever had intercourse 
after menarche. The recodes used are 
SEX1MTHDI-4, which describe whether 
a method was used at all the first time a 
woman had intercourse after menarche, 
and if so, what method(s). If she did 
report using a method at first intercourse 
after menarche, she was asked what 
method she used and what other 
method(s) she used at the same time, if 
any.
Current contraceptive status
This recode (recode = CONSTAT1) 
is a measure of current contraceptive 
use during heterosexual vaginal 
intercourse. The primary purpose of this 
recode is to measure risk of pregnancy; 
the secondary purpose is to measure risk 
of sexually transmitted diseases. All 
respondents are classified by current 
contraceptive status, first into those who 
are using contraception in the month of 
interview and those who are not.
Those who are not using contra­
ception are classified into the following 
categories, which may be viewed as ‘‘not 
at risk of unintended pregnancy’’:
•  They are currently pregnant or 
postpartum.
•  They are trying to become pregnant.
•  They have never had intercourse or 
they have not had intercourse within 
the 3 months before the interview.
•  They or their partner is sterile—  
either nonsurgically or surgically for 
noncontraceptive reasons.
A final category of nonusers 
comprises those who are not using, but 
they have had intercourse in the 3 
months before the interview. These are 
generally classified as ‘‘at risk of 
unintended pregnancy.’’
Those who are using contraception 
are classified by the method or methods 
they are using. Those who are using 
more than one method are classified by 
the most effective method they are 
using. If multiple contraceptive methods
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are being used at the time of interview, 
up to three additional methods are coded 
into separate variables (CONSTAT2- 
CONSTAT4), in order of their 
effectiveness. (Very few respondents 
reported four methods in a month, and 
none reported more than four.)
This report presents results from the 
CONSTAT1 recode (the most effective 
method currently used) in Tables 4-11, 
and the results of CONSTAT1-4 
(all methods currently used) in 
Tables 12-14. The categories of current 
contraceptive status are defined in the 
following way, in two broad groups—  
those not using contraception and those 
using contraception. The categories of 
nonusers of contraception are described 
first.
Noncontraceptors
Nonsurgically sterile—A  woman was 
classified as nonsurgically sterile if she 
reported that it was impossible for her 
or her husband or cohabiting partner to 
have a baby for any reason other than 
surgical sterilization. Nonsurgical 
reasons for sterility include menopause; 
sterility from accident, illness, 
congenital causes; or unexplained 
inability to conceive.
Surgically sterile (fem ale- 
noncontraceptive)— If a woman was 
surgically sterile at the time of interview 
for noncontraceptive reasons, then she 
was classified as surgically sterile 
(female-noncontraceptive). ‘‘Surgically 
sterile’’ means that the woman is 
completely unable to have a baby due to 
an operation. ‘‘Noncontraceptive’’ 
reasons include medical reasons such as 
trouble with female reproductive organs 
and high likelihood of miscarrying or 
having an unhealthy baby. Most of those 
classified in this category were women 
who had had a hysterectomy.
Pregnant—The recode RCURPREG 
was defined as ‘‘yes, currently 
pregnant’’ if the woman answered ‘‘yes’’ 
to either of these questions:
“Are you pregnant now?” or for those 
in doubt, ‘‘Do you think you are 
probably pregnant or not?” If the 
recode RCURPREG = ‘‘yes,’’ then 
CONSTAT1 was coded ‘‘pregnant.’’
Seeking pregnancy—A woman was 
classified as seeking pregnancy if she 
reported that she was not using a 
method at the time of interview because 
she or her partner wanted her to become 
pregnant as soon as possible.
Postpartum— A woman was classified 
as postpartum if she reported that she 
was not currently using a method, was 
not trying to become pregnant, and her 
last pregnancy had ended 6 weeks or 
less before the time of interview.
Other nonusers—Women who reported 
that they were using no contraceptive 
methods for any reason in the month of 
interview and could not be otherwise 
classified were considered nonusers. 
Included are:
•  Women who never had (voluntary) 
intercourse since their first menses.
•  Women who have had intercourse, but 
not in the 3 months prior to interview.
•  Women who had intercourse at some 
time in the 3 months prior to 
interview but were not using a 
method in the month of interview.
Contraceptors
Women in the NSFG used a ‘‘Life 
History Calendar’’ to record the month 
and year in which significant events 
happened in their lives, including 
marriages and cohabitations, and births 
and other pregnancies. Women used 
their life history calendars to help them 
answer more accurately about 
contraceptive use, both ever in their 
lives, and in the 3-4 years prior to the 
date of interview (for example, January 
2003 to the month of interview for 
women interviewed in 2006). The 
interviewer asked whether the 
respondent had ever used each of about 
22 methods, and showed her a card 
listing these 22 methods (all the 
methods that were currently available in 
the United States). Next, the interviewer 
asked the respondent to record on the 
life history calendar the contraceptive 
methods the respondent used each 
month from January 2003 (or her first 
intercourse if it was later than January 
2003) to the month of interview, if she 
was interviewed in 2006. If she was 
interviewed in 2008, she would be asked 
to record the methods she used in
January 2005 to the month of interview. 
The interviewer would read the following 
to the respondent and help her fill in the 
information on the life history calendar.
ED-4b. “I  need to fin d  out about 
the birth control methods you used 
each month between (DATE OF 
FIRST METHOD USE OR 
JANUARY xxxx) and (DATE OF 
INTERVIEW). Remember to include 
methods men use—such as condoms, 
vasectomy, and withdrawal— in your 
answer.
Looking at the methods on Card 37, 
please write the methods you used 
each month on the calendar. I  need to 
know about all the methods you used, 
so if  you used more than one method 
in a month, please record all the 
methods you used that month.”
They then reviewed the entries for 
each month and the interviewer entered 
the methods into the computer for each 
month. This recording continued through 
the month of the interview. The method 
or methods used in the month of 
interview comprise the methods used 
in the current contraceptive status 
classification in Table 4—14.
If the woman reported using two or 
more methods in the month of interview, 
she was classified by the most effective 
method she used for CONSTAT1.
Priority was given to contraceptive 
methods in the following order:
Female (contraceptive) sterilization 
had the highest priority, followed by 
male (contraceptive) sterilization, 
Norplant™ or Implanon™ implant, 
Lunelle™ (1-month injectable), 
Depo-Provera™ (3-month 
injectable), pill, contraceptive patch, 
contraceptive ring, morning-after 
pill (emergency contraception),
IUD, diaphragm (with or without 
jelly or cream), male condom, 
female condom or vaginal pouch, 
foam, cervical cap, Today™ sponge, 
suppository or insert, jelly or cream 
(without diaphragm), periodic 
abstinence by natural family 
planning or temperature rhythm 
methods, periodic abstinence by 
calendar rhythm method, 
withdrawal, and other methods.
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Thus, in Tables 4 -11 , if a woman or 
couple was using the pill and the male 
condom, they would be classified as 
using the pill, because it has a lower 
failure rate. In Tables 12-14, however, 
the use of both methods would be 
recorded.
Education
Highest grade or degree (recode = 
HIEDUC). This is based on a series of 
questions that measure the highest 
degree received as well as the highest 
grade or year of school completed. The 
categories of HIEDUC were defined as 
follows:
No high school diploma or
GED— The woman has not received 
a high school degree, General 
Educational Development high 
school equivalency diploma (GED), 
or college diploma.
High school diploma or GED—The 
highest degree the woman obtained 
is a high school diploma or GED, 
and her highest completed grade of 
school is 12 or lower.
Some college, no bachelor’s 
degree— The highest degree the 
woman obtained is a high school 
diploma or GED, but the highest 
grade of school completed is higher 
than 12, or the highest degree is an 
Associate’s degree.
B achelor’s degree or higher—The 
woman reported having a college or 
university degree at the bachelor’s 
level or higher, regardless of highest 
grade completed.
The tables in this report show data 
for education only for women aged 
22-44 years at interview because large 
percentages of women 15-21 years of 
age are still attending school. Using the 
full age range of 15-44 would 
misclassify many young women still 
attending school as having low 
educational attainment.
Education of respondent’s 
mother
This is a measure (recode = 
EDUCMOM) of the respondent’s 
mother’s (or mother-figure’s)
educational attainment. For women who 
had not lived with both biological or 
both adoptive parents from birth or 
adoption to age 18, this question was 
asked to determine whether she had a 
mother or mother-figure:
‘‘Who, i f  anyone, do you think o f as 
the woman who mostly raised you 
when you were growing up?”
Response categories included: biological 
mother, adoptive mother, stepmother, 
father’s girlfriend, foster mother, 
grandmother, other female relative, 
female nonrelative, no such person, or 
other.
All respondents, except for those 
who did not identify a mother figure, 
were then asked:
“Please look at Card 11. What is 
the highest level o f education (your 
mother/she) completed?”
-  Less than high school
-  High school graduate or GED
-  Some college but no degree
-  2-year college degree (e.g., 
Associate’s degree)
-  4-year college graduate (e.g., BA, 
BS)
-  Graduate or professional school
These were combined into the same 
four categories as was the respondent’s 
education: less than high school; high 
school graduate or GED; some college 
including 2-year degrees; and Bachelor’s 
degree or higher.
Effectiveness of contraceptive 
methods
The 13.5% of contraceptive users 
who were using more than one method 
in the month before the interview were 
classified in Tables 4-11 by the most 
‘‘effective’’ method they were using.
This section defines ‘‘effectiveness,’’ 
and how it is measured in the NSFG.
The ranking of the effectiveness of 
methods uses data (when available) and 
other knowledge to estimate the failure 
rate for each method when used by a 
national sample of users. A failure rate 
is simply the percent who have a 
pregnancy in the first 12 months of 
using the method. Much of this
knowledge is based on analysis of data 
from previous cycles of the NSFG and 
from clinical trials (e.g., 21,22). This 
measure is sometimes called ‘‘typical 
use,’’ or ‘‘use-effectiveness,’’ and is the 
best estimate of the likely failure rate 
for a national cross-section of users. 
‘‘Perfect use,’’ which is often measured 
in clinical trials, is the failure rate 
obtained when a method is used by a 
selected sample of participants who are 
instructed how to use the method 
consistently and correctly; clinical-trial 
failure rates are usually lower than 
failure rates in representative national 
samples (21,22).
Two recent sources (21,22) were 
used to obtain the typical-use failure 
rates as estimated from previous cycles 
of the NSFG. These rates are shown in 
Table A in the text. They are: female 
sterilization and male sterilization (less 
than 1%, most effective), implant (1%), 
injectable (7%), pill (9%), male 
condom (17%), withdrawal (18%), 
periodic abstinence (25%), and 
spermicides (29%, least effective).
Along with the failure rates shown 
previously, two other factors were 
considered: One of these was an attempt 
to preserve comparability with previous 
cycles of the NSFG. Priority was given to 
comparability when the differences in 
failure rates between some methods were 
very small. The rankings for the newer 
methods and those used by very small 
proportions of women were assigned 
based on the best information available. 
Therefore, if a woman reported that she 
had used the pill and the condom in the 
last month, in Tables 4-11, she was 
classified as using the pill, because the pill 
has a lower failure rate (9%) than the 
condom (17%). In Tables 12-14, however, 
both the pill use and the condom use 
would be recorded.
Ever-use of birth control 
methods
These data are based on multiple 
series of questions, the first of which 
begins like this:
‘ ‘Card 30 lists methods that some
people use to prevent pregnancy or to
prevent sexually transmitted disease.
As I  read each one, please tell me if
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you have ever used it fo r  any reason. 
Please answer yes even if  you have 
only used the method once.
-  Have you ever used birth control 
pills?
-  Have you ever used condoms or 
rubbers with a partner?
-  Have you ever had sex with a 
partner who had a vasectomy?
-  Have you ever used Depo- 
Provera™, an injectable (or shot) 
given once every 3 months?
-  Have you ever used Lunelle™, a 
once-a-month injection?
-  Have you ever had sex with a 
partner who used withdrawal or 
‘‘pulling out’’?”
This series of questions continued 
until 11 methods had been asked about 
individually. Then, the respondent was 
asked the following:
‘‘On the right side o f Card 30 is a 
list o f some other methods o f birth 
control. Which, if  any o f the 
methods listed on that side o f the 
card have you ever used? Please 
tell me the method even if  you have 
only used it once.”
The methods that were listed on the 
right side of the card are: Hormonal 
implant (Norplant™ or Implanon™); 
IUD, coil, loop; cervical cap; 
diaphragm; female condom, vaginal 
pouch; foam; jelly or cream; 
suppository, insert; Today™ sponge, and 
other method. The interviewer would 
record every method that the respondent 
had used.
Other sections of the interview, 
which captured a woman’s use of 
contraceptive methods at specific 
instances or periods of intercourse, were 
used to ensure that ‘‘ever use’’ of these 
methods were complete. The additional 
information came from her life history 
calendar, a month-by-month record of 
birth control; the method she used the 
first time she had intercourse; the 
method she used the last time she had 
intercourse; and whether she had 
stopped using the method because of 
dissatisfaction.
This variable (Recode =
RMARITAL) is based on the following 
question in the interview:
‘‘Now I ’d like to ask about your
marital status and living together.
Please look at Card 1. What is your
current marital or cohabiting status?’’
-  Married
-  Not married but living together 
with a partner o f the opposite sex
-  Widowed
-  Divorced
-  Separated, because you and your 
spouse are not getting along
-  Never been married.
In this report, the categories 
widowed, divorced, and separated were 
combined into the ‘‘formerly married’’ 
category because of limitations of 
sample size.
Parity
This refers to the number of live 
births (recode = PARITY) the woman 
has had. For example, a woman 
classified as ‘‘parity 0’’ has never had a 
live birth. ‘‘Parity 1’’ means that she has 
had one live birth.
Poverty level income at 
interview
The poverty index ratio (recode = 
POVERTY) is measured for the year 
before the year of interview. It was 
calculated by dividing the total family 
income by the weighted average 
threshold income of families whose 
head of household was under 65 years 
of age, based on the poverty levels 
defined by the U.S. Census Bureau for 
the year preceding the interview. That is, 
if the interview took place in 2006, the 
respondent was asked to provide the 
total family income for 2005 and 
POVERTY would be calculated using 
the 2005 Census definitions. This 
definition of poverty status takes into 
account the number of persons in the 
family. Total family income includes 
income from all sources for all members 
of the respondent’s family.
Marital status at interview For example, the Census-defined 
poverty threshold for a family of four in 
2005, was $19,971. So, if the total 
family income was $40,000, the income 
relative to the poverty level would be 
200 ($40,000/19,971) x 100 = 200.29) 
and a respondent would be classified in 
the category ‘‘150-299%.’’
The tables in this report show data 
by poverty-level income only for 
women aged 20-44 years at interview. 
Reports of income by younger women 
are likely to be inaccurate because 
younger respondents are more likely to 
be trying to report the income of their 
parent(s) and less likely to be 
contributors to family income 
themselves.
For 1,452 (781 women and 671 
men) of the 13,495 respondents, or 
10.8%, total family income for the year 
preceding the NSFG interview was not 
ascertained, and was imputed.
Race and Hispanic origin
Women were classified into a 
Hispanic origin or race category, based 
on the recode variable (recode = 
HISPRACE2), HISPRACE, and the 
intermediate variable, NUMRACE (a 
count of the number of races the 
respondent chose). HISPRACE has these 
values:
1 = Hispanic
2 = Non-Hispanic white
3 = Non-Hispanic black
4 = Non-Hispanic other
NUMRACE is dichotomous: 1 = single 
race, 2 = multiple races.
For respondents who were Hispanic 
(HISPRACE = 1) or who were of only 
1 race (NUMRACE = 1), HISPRACE2 
= HISPRACE. If NUMRACE = 2, then 
HISPRACE2 = 4. The categories of 
HISPRACE2 are:
1 = Hispanic (regardless of race
reporting)
2 = Non-Hispanic white, single race
3 = Non-Hispanic black, single race
4 = Non-Hispanic other single race
or multiple race
For some tables, there are sufficient 
numbers of non-Hispanic Asian, single­
race respondents to report statistical
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results for this subgroup of category 4, 
non-Hispanic other single or multiple 
race. There are too few respondents in 
the other subgroups to report results for 
them separately.
Interpretation of data by race and 
Hispanic origin
Data are shown by race and 
Hispanic origin in the tables because 
NCHS is frequently asked to provide 
data separately for white, black, and 
Hispanic women. Race is associated 
with a number of indicators of social 
and economic status. Measures of 
socioeconomic status (e.g., education 
and income) are not always available for 
the point in time when the event being 
studied occurred. While characteristics 
such as education and income change 
over time, race and ethnicity do not 
change, so they can be used at all points 
in time as proxies for socioeconomic 
status. Differences among white, black, 
and Hispanic women in the variables 
presented in the tables may be related to 
the lower income and educational levels 
of black and Hispanic women (36,
Tables 222, 223, 262, 569, 602, 669,
671, 689, 699) their limited access to 
health care and health insurance, the 
communities in which they live (37), 
and other factors.
Sexually experienced
In this report, a female is sexually 
experienced if she has ever had vaginal, 
heterosexual intercourse at least once in 
her life after menarche. Tables 1 and 2 
of this report are based on this group of 
women. This is measured by the 
HADSEX recode.
Sexual intercourse
In this report, sexual intercourse 
only includes vaginal intercourse 
between a male and a female.
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Appendix III. Details 
on the Surveys of 
Contraceptive Use 
Shown in Table F
The United Nations Population 
Division, Section on Fertility and 
Family Planning, provided the following 
details on the surveys summarized in 
Table F of this report. See the website 
cited in Table F for more information.
Australia
Name of survey: Australian Study of 
Health and Relationships.
Data collection period: Mid-2001 to 
mid-2002.
Data collection method: Computer- 
assisted telephone interview.
Sample size: 19,307 men and women. 
Questions on contraceptive use were 
administered to 9,134 sexually active 
women aged 16-59.
Sample weights: Data were adjusted to 
match the Australian population (age, 
sex, area of residence) based on the 
2001 Census.
Response rate: 77.6%.
Contraceptive methods: Respondents 
were allowed to indicate more than one 
contraceptive method. The survey 
indicated that the overall contraceptive 
prevalence was 70.8%. Questions were 
asked of women who had had 
intercourse in the last 12 months.
Belgium
Name of survey: Enquete de sante par 
interview.
Data collection period: 2004.
Data collection method: Self-reported 
paper questionnaire.
Sample size: 12,650 persons. Questions 
on contraceptive use were administered 
to sexually active women aged 15-49.
Sample weights: Data were adjusted to 
match basic population characteristics. 
Response rate: 61.4% of households 
contacted.
Contraceptive methods: Questions refer 
to methods used during the previous 12 
months. Respondents were allowed to 
indicate more than one contraceptive 
method. The tabulated results did 
reclassify methods by main method. 
Questions were asked of women who 
had had intercourse in the last 12 
months.
France
Name of survey: Enquete Cohorte 
Contraception 2000.
Data collection period: October 2000 
and January 2001.
Data collection method: Computer- 
assisted telephone interview.
Sample weights: Data were adjusted 
after post-stratification to make the 
structure of the sample more comparable 
to that of the female population of 
metropolitan France. Data were also 
adjusted for age, marital status, activity 
status, and educational attainment.
Sample size: 3,155 women aged 18-44. 
Response rate: Around 90%. 
Contraceptive methods: The 
questionnaire did not distinguish 
between sterilizations for contraceptive 
and medical reasons. Data on 
contraceptive use to women married or 
in union were provided to the United 
Nations by INSERM.
Netherlands
Name of survey: Geboorteregeling 2003 
(Birth Control in the Netherlands Survey
2003).
Data collection period: February to May 
2003.
Data collection method: Computer- 
assisted personal interview.
Sample weights: Data were adjusted to 
match the population (age, sex, area of 
residence, nationality, and marital status 
of women).
Sample size: 14,221 households (men 
and women aged 18-62). Questions on 




Name of survey: Survey on 
Contraceptive Use 2005.
Data collection period: October 2005. 
Data collection method: Web panel. 
Sample size: 5,000 women aged 20-44 
who were sexually active in the 
previous 3 months.
Response rate: 41%.
Contraceptive methods: Women who 
provided no information on the 
contraceptive method used were 
classified as not using contraception.
Portugal
Name of survey: Inquerito Nacional de 
Saude 2005-2006.
Data collection period: February 2005 
and February 2006.
Data collection method: Computer- 
assisted personal interview.
Sample size: 41,193 Portuguese 
residents. Questions on contraceptive 
use were administered to women aged
15-55.
Response rate: 76%.
Contraceptive methods: United Nations 
Population Division (UNPD) estimated 
the contraceptive prevalence for women 
20-49 based on data on contraceptive 
prevalence for 5-year age groups using 
the UNPD publication ‘‘World 
Population Prospects 2006’’ as the 
population weights for women in 
different age groups. The data published 
by the United Nations refer to all 
women of reproductive age, regardless 
of marital status or recent sexual 
activity.
Spain
Name of survey: Encuesta de 
Fecundidad y Valores 2006.
Data collection period: 17 April to 31 
May 2006.
Data collection method: Face-to-face 
interview.
Sample weights: Data were adjusted to 
ensure that the weighted sample 
distribution across 50 provinces matched 
the population.
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Sample size: 10,000 women aged 15 or 
over residing in Spain. Questions on 
contraceptive use were administered to 
women aged 15-49.
Response rate: Over 90%.
United Kingdom
Name of survey: 2007 Omnibus Survey. 
Data collection period: Modules on 
contraception and sexual health were 
administered in August, October, and 
December 2007 and March 2008.
Data collection method: Computer- 
assisted personal interview.
Sample weights: Data were adjusted to 
ensure that the weighted sample 
distribution across regions and across 
age-sex groups matched that in the 
overall population.
Sample size: 1,200 adults aged 16 or 
over. Questions on contraceptive use 
were administered to women aged
16-49.
Response rate: Around 70%. 
Contraceptive methods: Respondents 
were allowed to indicate more than one 
contraceptive method. The survey 
indicated that the overall contraceptive 
prevalence (the percent using any 
contraceptive method) for married or in 
union women was 82%.
United States
The data shown for the United States in 
Table F were taken from Table 7 . For 
married couples, the data were taken 
directly from Table 7 . F or all marital 
statuses, the data are from the total 
column of Table 7, divided by the 
proportion who had intercourse in the 
last 3 months (80.8%). This makes the 
percentages for the United States more 
comparable to the percentages for 
Australia, Belgium, and Norway.
Vital and Health Statistics 
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Programs and Collection Procedures—This type of report 
describes the data collection programs of the National Center 
for Health Statistics. Series 1 includes descriptions of the 
methods used to collect and process the data, definitions, and 
other material necessary for understanding the data.
Data Evaluation and Methods Research—This type of 
report concerns statistical methods and includes analytical 
techniques, objective evaluations of reliability of collected 
data, and contributions to statistical theory. Also included are 
experimental tests of new survey methods, comparisons of 
U.S. methodologies with those of other countries, and as of 
2009, studies of cognition and survey measurement, and final 
reports of major committees concerning vital and health 
statistics measurement and methods.
Analytical and Epidemiological Studies—This type of 
report presents analytical or interpretive studies based on vital 
and health statistics. As of 2009, Series 3 also includes 
studies based on surveys that are not part of continuing data 
systems of the National Center for Health Statistics and 
international vital and health statistics reports.
Data From the National Health Interview Survey—This 
type of report contains statistics on illness; unintentional 
injuries; disability; use of hospital, medical, and other health 
services; and a wide range of special current health topics 
covering many aspects of health behaviors, health status, and 
health care utilization. Series 10 is based on data collected in 
this continuing national household interview survey.
Data From the National Health Examination Survey, the 
National Health and Nutrition Examination Surveys, and 
the Hispanic Health and Nutrition Examination Survey—
In this type of report, data from direct examination, testing, 
and measurement on representative samples of the civilian 
noninstitutionalized population provide the basis for (1) 
medically defined total prevalence of specific diseases or 
conditions in the United States and the distributions of the 
population with respect to physical, physiological, and 
psychological characteristics, and (2) analyses of trends and 
relationships among various measurements and between 
survey periods.
Data From the National Health Care Survey—This type of 
report contains statistics on health resources and the public’s 
use of health care resources including ambulatory, hospital, 
and long-term care services based on data collected directly 
from health care providers and provider records.
Data on Mortality—This type of report contains statistics on 
mortality that are not included in regular, annual, or monthly 
reports. Special analyses by cause of death, age, other 
demographic variables, and geographic and trend analyses 
are included.
Data on Natality, Marriage, and Divorce—This type of 
report contains statistics on natality, marriage, and divorce 
that are not included in regular, annual, or monthly reports. 
Special analyses by health and demographic variables and 
geographic and trend analyses are included.
Data From the National Survey of Family Growth—These 
reports contain statistics on factors that affect birth rates, 
including contraception and infertility; factors affecting the 
formation and dissolution of families, including cohabitation, 
marriage, divorce, and remarriage; and behavior related to 
the risk of HIV and other sexually transmitted diseases. 
These statistics are based on national surveys of women and 






Series 4. Documents and Committee Reports—These are final 
reports of major committees concerned with vital and health 
statistics and documents. The last Series 4 report was 
published in 2002. As of 2009, this type of report is included 
in Series 2 or another appropriate series, depending on the 
report topic.
International Vital and Health Statistics Reports—This 
type of report compares U.S. vital and health statistics with 
those of other countries or presents other international data of 
relevance to the health statistics system of the United States. 
The last Series 5 report was published in 2003. As of 2009, 
this type of report is included in Series 3 or another series, 
depending on the report topic.
Cognition and Survey Measurement—This type of report 
uses methods of cognitive science to design, evaluate, and 
test survey instruments. The last Series 6 report was 
published in 1999. As of 2009, this type of report is included 
in Series 2.
Data From the Institutionalized Population Surveys—
The last Series 12 report was published in 1974. Reports 
from these surveys are included in Series 13.
Data on Health Resources: Manpower and Facilities—
The last Series 14 report was published in 1989. Reports on 
health resources are included in Series 13.
Data From Special Surveys—This type of report contains 
statistics on health and health-related topics collected in 
special surveys that are not part of the continuing data 
systems of the National Center for Health Statistics. The last 
Series 15 report was published in 2002. As of 2009, reports 
based on these surveys are included in Series 3.
Compilations of Advance Data From Vital and Health 
Statistics—The last Series 16 report was published in 1996. 
All reports are available online, and so compilations of 
Advance Data reports are no longer needed.
Data From the National Mortality and Natality Surveys—
The last Series 22 report was published in 1973. Reports 
from these sample surveys, based on vital records, are 
published in Series 20 or 21.
Compilations of Data on Natality, Mortality, Marriage, and 
Divorce—The last Series 24 report was published in 1996. 
All reports are available online, and so compilations of reports 
are no longer needed.
For answers to questions about this report or for a list of reports published 
in these series, contact:
Information Dissemination Staff 
National Center for Health Statistics 
Centers for Disease Control and Prevention 
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